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A B S T R A C T
Background
Admission avoidance hospital at home provides active treatment by healthcare professionals in the patient’s home for a condition that
otherwise would require acute hospital inpatient care, and always for a limited time period. This is the third update of the original
review.
Objectives
To determine the effectiveness and cost of managing patients with admission avoidance hospital at home compared with inpatient
hospital care.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, two other databases, and two
trials registers on 2 March 2016. We checked the reference lists of eligible articles. We sought unpublished studies by contacting
providers and researchers who were known to be involved in the field.
Selection criteria
Randomised controlled trials recruiting participants aged 18 years and over. Studies comparing admission avoidance hospital at home
with acute hospital inpatient care.
Data collection and analysis
We followed the standard methodological procedures expected by Cochrane and the Effective Practice and Organisation of Care
(EPOC) Group. We performed meta-analysis for trials that compared similar interventions and reported comparable outcomes with
sufficient data, requested individual patient data from trialists, and relied on published data when this was not available. We used the
GRADE approach to assess the certainty of the body of evidence for the most important outcomes.
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Main results
We included 16 randomised controlled trials with a total of 1814 participants; three trials recruited participants with chronic obstructive
pulmonary disease, two trials recruited participants recovering from a stroke, six trials recruited participants with an acute medical
condition who were mainly elderly, and the remaining trials recruited participants with a mix of conditions. We assessed the majority
of the included studies as at low risk of selection, detection, and attrition bias, and unclear for selective reporting and performance
bias. Admission avoidance hospital at home probably makes little or no difference on mortality at six months’ follow-up (risk ratio
(RR) 0.77, 95% confidence interval (CI) 0.60 to 0.99; P = 0.04; I2 = 0%; 912 participants; moderate-certainty evidence), little or no
difference on the likelihood of being transferred (or readmitted) to hospital (RR 0.98, 95% CI 0.77 to 1.23; P = 0.84; I2 = 28%; 834
participants; moderate-certainty evidence), and may reduce the likelihood of living in residential care at six months’ follow-up (RR
0.35, 95% CI 0.22 to 0.57; P < 0.0001; I2 = 78%; 727 participants; low-certainty evidence). Satisfaction with healthcare received may
be improved with admission avoidance hospital at home (646 participants, low-certainty evidence); few studies reported the effect on
caregivers. When the costs of informal care were excluded, admission avoidance hospital at home may be less expensive than admission
to an acute hospital ward (287 participants, low-certainty evidence); there was variation in the reduction of hospital length of stay,
estimates ranged from a mean difference of -8.09 days (95% CI -14.34 to -1.85) in a trial recruiting older people with varied health
problems, to a mean increase of 15.90 days (95% CI 8.10 to 23.70) in a study that recruited patients recovering from a stroke.
Authors’ conclusions
Admission avoidance hospital at home, with the option of transfer to hospital, may provide an effective alternative to inpatient care
for a select group of elderly patients requiring hospital admission. However, the evidence is limited by the small randomised controlled
trials included in the review, which adds a degree of imprecision to the results for the main outcomes.
P L A I N L A N G U A G E S U M M A R Y
’Hospital at home’ services to avoid admission to hospital
What is the aim of this review?
The aim of this Cochrane review was to find out if providing healthcare in an admission avoidance hospital at home setting improves
patient health outcomes and reduces cost to the health service.
Key messages
Admission avoidance hospital at home probably makes little or no difference to patient health outcomes, may increase the chances of
living at home at six months’ follow-up, and may be slightly less expensive. However, the findings are not precise due to the small size
of the studies included in the review.
What was studied in this review?
There continues to be more demand for acute hospital beds than there are beds. One way to reduce reliance on hospital beds is to
provide people with acute health care at home, sometimes called ’hospital at home’. We systematically reviewed the literature on the
effect of providing hospital at home services to avoid hospital admission for adults.
What are the main results of this review?
Admission avoidance hospital at home, with the option of transfer to hospital, may provide an effective alternative to inpatient care for
a select group of elderly patients requiring hospital admission. We found 16 studies, of which six were identified for this update. Three
studies recruited participants with chronic obstructive (lung) disease, two recruited participants recovering from a stroke, six recruited
participants with a (sudden or short-term) medical condition who were mainly elderly, and the remaining studies recruited participants
with a mix of conditions. The studies showed that when compared to in-hospital care, admission avoidance hospital at home services
probably make little or no difference to patient health outcomes or to the likelihood of being taken to hospital, and may increase the
chances of living at home at six months’ follow-up. Patients who receive care at home may be more satisfied than those who are in
hospital, but it is not known how this type of health care affects the caregivers who support them. With respect to costs, it is uncertain
if hospital at home services reduce or increase length of stay or cost to the health service; when the costs for caregivers are taken into
account any difference in cost may disappear.
How up to date is the review?
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The review authors searched for studies published up to March 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Admission avoidance hospital at home compared with inpatient admission for older people requiring admission to hospital
Patient or population: Older people requiring hospital admission
Settings: Home
Intervention: Admission avoidance hospital at home
Comparison: Inpat ient care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Certainty of the evidence
(GRADE)
Assumed risk Corresponding risk
Inpatient admission Admission avoidance hos-
pital at home
Transfer (or readmission)
to hospital for patients
with a medical condition
using individual patient
data and published data
(3 to 12 months’ follow-up)
Study population RR 0.98
(0.77 to 1.23)
834
(7 RCTs)
⊕⊕⊕o1
Moderate
254 per 1000 249 per 1000
(195 to 312)
M edium- risk population
340 per 1000 333 per 1000
(262 to 418)
M ortality at 6 months’ fol-
low-up
(using data from trialists
and published data)
Study population RR 0.77
(0.60 to 0.99)
912
(6 RCTs)
⊕⊕⊕o1
Moderate
240 per 1000 185 per 1000
(144 to 237)
M edium- risk population
196 per 1000 151 per 1000
(118 to 194)
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Living in an institutional
setting
at 6 months’ follow-up
Study population RR 0.35
(0.22 to 0.57)
727
(5 RCTs)
⊕⊕oo2
Low
161 per 1000 56 per 1000
(35 to 92)
M edium- risk population
151 per 1000 53 per 1000
(33 to 86)
Patient satisfaction Patients allocated to hospital at home care reported
higher levels of sat isfact ion, range 8% to 40%
- 646
(5 RCTs)
⊕⊕oo3
Low
Hospital and hospital at
home length of stay
Length of stay ranged f rom a mean reduct ion of -8.09
days (95% CI -14.34 to -1.85) to a mean increase of 15.
90 days (95% CI 8.10 to 23.70)
- 714
(7 RCTs)
⊕⊕oo2
Low
Cost Estimates (boot strapped mean dif ference) of health
service cost varied, f rom a lower cost at 3 months’ follow-
up for hospital at home of GBP 210.90 (95% CI GBP -
1025 to GBP 635.47), to a mean dif ference (lower cost
for hospital at home) per episode of immediate care of
GBP -304.72, 95% CI GBP -1112.35 to GBP 447.89
- 287
(2 RCTs)
⊕⊕oo4
Low
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RCT: randomised controlled trial; RR: risk rat io
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: We are very uncertain about the est imate.
1We downgraded the certainty of the evidence due to lack of precision.
2We downgraded the certainty of the evidence due to lack of precision and inconsistency.
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3We downgraded the certainty of the evidence, as only 31% of studies reported this outcome, and there is risk of detect ion
bias due to subject ive report ing of this outcome.
4We downgraded the certainty of the evidence, as only two studies reported a full cost analysis.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
6
A
d
m
issio
n
a
v
o
id
a
n
c
e
h
o
sp
ita
l
a
t
h
o
m
e
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
For several decades there has been an emphasis by health systems
around the world on avoiding admission to hospital, and in the last
10 years this has gained some momentum, reflecting the changing
demographic and also the relatively limited gain from discharging
patients early after a stay in hospital, given the universal trend for
shorter hospital lengths of stay. Cutting costs by avoiding admis-
sion to hospital in the first instance is the central goal of such
schemes. Other perceived benefits include reducing the risk of
adverse events associated with time in hospital and the potential
benefit of receiving rehabilitation within the home environment
(Brennan 2004). The type of patient treated in hospital at home
services varies between schemes, as does the use of technology.
Some schemes are designed to care for specific conditions, such as
chronic obstructive pulmonary disease, or provide specific skills,
such as parenteral nutrition (Mughal 1986). These schemes usu-
ally have close ties with acute hospitals and may be encouraged by
the different structure of incentives in insurance-based systems of
health care. However, many other hospital at home schemes lack
such a clear function and have an ’open-door’ policy covering a
large range of conditions.
Description of the condition
The demographic shift of a rising number of older people, com-
bined with the relative reduction in the number of working-age
adults contributing to the economy,make the provision of sustain-
able safe health care for older adults a major health concern for the
21st century. For example, in the UK nearly two-thirds (65%) of
people admitted to hospital are over 65 years old, and over the last
10 years there has been a 65% increase in the number of people
aged over 75 who have required secondary care (Cornwall 2012).
Healthcare decision-makers in a number of countries are attempt-
ing to reconfigure services to deal with the year-on-year increase
in hospital admissions, often with an inadequate evidence base
(Nolte 2008). These changes have raised concerns that the pressure
of delivering health care to greater numbers may be at odds with
the provision of person-centred, high-quality care (Royal College
of Physicians 2012).
Description of the intervention
Admission avoidance hospital at home provides co-ordinated,
multidisciplinary care in the home for people who would other-
wise be admitted to hospital. People are admitted to admission
avoidance hospital at home after assessment in the community by
their primary care physician, in the emergency department or a
medical admissions unit. Hospital at home may also provide hos-
pital-level care following early discharge from hospital (we have
conducted a parallel systematic review of early discharge hospital
at home, Shepperd 2009).
How the intervention might work
One aim of admission avoidance hospital at home is to reduce
the demand for acute hospitals beds; a second aim is to lower the
risk of functional decline from limited mobility that can occur
during an admission to hospital, particularly in frail older people,
by providing co-ordinated health care in a less restrictive environ-
ment and thereby giving patients the opportunity for continued
involvement in activities of daily living (Covinsky 2003).
Why it is important to do this review
Despite a policy emphasis on care closer to home (Monitor 2015),
it is not known if people admitted to admission avoidance hospital
at home have better or equivalent health outcomes compared with
those receiving inpatient hospital care. It is also unknown whether
the provision of hospital at home results in a reduction or increase
in health service costs.
O B J E C T I V E S
To determine the effectiveness and cost of managing patients with
admission avoidance hospital at home compared with inpatient
hospital care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials.
Types of participants
This review included evaluations of admission avoidance hospital
at home schemes involving people aged 18 years and over. We did
not include people with long-term care needs unless they required
admission to hospital for an acute episode of care. We excluded
evaluations of obstetric, paediatric, and mental health hospital at
home schemes from the review since our preliminary literature
searches suggested that separate reviews would be justified for each
of these groups. For the purpose of this review, we defined older
patients as those aged 65 years and older.
7Admission avoidance hospital at home (Review)
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Types of interventions
Studies comparing admission avoidance hospital at home with
acute hospital inpatient care. The admission avoidance hospital
at home studies may admit patients directly from the community
thereby avoiding physical contact with the hospital, or may admit
from the emergency room. We used the following definition to
determine if studies should be included in the review: hospital at
home is a service that can avoid the need for hospital admission
by providing active treatment by healthcare professionals in the
patient’s home for a condition that otherwise would require acute
hospital inpatient care, and always for a limited time period. In
particular, hospital at home has to offer a specific service to patients
in their home requiring healthcare professionals to take an active
part in the patients’ care. If hospital at home were not available,
then the patient would be admitted to an acute hospital ward. We
have therefore excluded the following services from this review:
• services providing long-term care;
• services provided in outpatient settings or postdischarge
from hospital; and
• self care by the patient in their home such as self
administration of an intravenous infusion.
Types of outcome measures
Main outcomes
1. Mortality
2. Transfer (or readmission) to hospital
Other outcomes
1. Functional status
2. Quality of life or self reported health status
3. Cognitive function
4. Depression
5. Clinical outcomes
6. Place of residence at follow-up (living in a residential
setting)
7. Patient satisfaction
8. Caregiver outcomes
9. Health professionals’ views
10. Length of stay in hospital and hospital at home
11. Cost
12. Use of other health services and informal care
Search methods for identification of studies
Electronic searches
We searched the following databases on 2 March 2016 for refer-
ences published since the last version of this review.
• Cochrane Central Register of Controlled Trials
(CENTRAL) (Issue 2 of 12, 2016), including the Effective
Practice and Organisation of Care (EPOC) Group Specialised
Register, Wiley (search date 2 March 2016).
• MEDLINE (1946 to 2 March 2016), MEDLINE and
MEDLINE In-Process and Other Non-Indexed Citations,
OvidSP.
• EMBASE (1974 to 1 March 2016), OvidSP.
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature) (1980 to 2 March 2016), EBSCOhost.
• EconLit (1886 to 2 March 2016), ProQuest.
There were no restrictions to publication status or language of
publication. See Appendix 1 and Appendix 2 for details of the
search strategies used.
Searching other resources
We checked the reference lists of articles identified electronically
for evaluations of hospital at home and obtained potentially rele-
vant articles. We conducted a citation search of all included stud-
ies in the previous version of this review using the Science Cita-
tion Index (search date 22 April 2015). We searched clinical trial
registries using the terms ’hospital at home’ and ’admission’ for
open, interventional trials that recruited adults and older adults (
ClinicalTrials.gov) and the term ’hospital at home’ (who.int/ictrp).
Data collection and analysis
Selection of studies
Two review authors (SS, DGB) read all the abstracts in the records
retrieved by the electronic searches to identify potentially eligible
publications. We retrieved full-text papers for these publications,
and two review authors (SS and SI, or SS and DGB) indepen-
dently assessed their eligibility. We selected studies for the review
according to the prespecified inclusion criteria and resolved dis-
agreements by discussion.
Data extraction and management
Two review authors (SS and SI, or SS and DGB) independently
completed data extraction using a good-practice extraction form
developed by Cochrane that was modified and amended for the
purposes of this review (EPOC 2015a).
Assessment of risk of bias in included studies
Two review authors (SS and SI, or SS and DGB) independently
assessed the risk of bias of the included studies using the suggested
’Risk of bias’ criteria for EPOC reviews (EPOC 2015b):
1. random sequence generation;
8Admission avoidance hospital at home (Review)
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2. allocation concealment;
3. baseline outcome measurement;
4. baseline characteristics;
5. blinding of participants and personnel;
6. blinding of outcome assessment;
7. incomplete outcome data;
8. selective reporting of outcomes.
Certainty of the evidence
We graded our confidence in the evidence by creating a ’Sum-
mary of findings’ table using the approach recommended by the
GRADE (Grades of Recommendation, Assessment, Development
and Evaluation) Working Group, in Guyatt 2008, and the specific
guidance developed by EPOC (EPOC 2015c). We included the
main outcomes of mortality and hospital readmission, as well as
place of residence at follow-up, patient satisfaction, and costs. We
used the five GRADE considerations (study limitations, consis-
tency of effect, imprecision, indirectness, and risk of bias) to assess
the certainty of the evidence as it relates to the main outcomes
(Guyatt 2008).We usedmethods and recommendations described
in Section 8.5 and Chapter 12 of the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011).
Measures of treatment effect
We conducted an individual patient data (IPD) meta-analysis in
a subgroup of trials evaluating specific outcomes in the more ho-
mogeneous populations. We contacted the investigators of 10 of
the included trials by email or telephone, inviting them to con-
tribute data to the hospital at home admission avoidance collab-
orative review. We sent up to four reminders. We excluded five
trials from the IPD meta-analysis (n = 518 participants), though
included these trials in the review, as they recruited participants
who differed substantially from the populations in the other trials,
in terms of having an acute short-term condition (community-
acquired pneumonia, Richards 2005), having significant cogni-
tive impairment (Tibaldi 2004), cellulitis (Corwin 2005), expe-
riencing febrile neutropenia as a result of chemotherapy (Talcott
2011), and having neuromuscular disease and a respiratory infec-
tion (Vianello 2013). One small trial was published as a meeting
abstract only; we tried to contact the authors for further informa-
tion but did not receive a reply (Andrei 2011, n = 45).
For the IPD meta-analysis, where at least one event was reported
in both study groups in a trial, we used Cox regression models to
calculate the log hazard ratio and its standard error for mortality
for each data set. We included randomisation group (admission
avoidance hospital at home versus control), age (above or below the
median), and gender in the models. We combined the calculated
log hazard ratios using fixed-effect inverse variance meta-analysis
(Deeks 2001). The pooled effect is expressed as the hazard ratio for
hospital at home compared with usual hospital care. If there were
no events in one group, we used the Peto odds ratio method to
calculate a log odds ratio from the sum of the log-rank test ’O-E’
statistics from a Kaplan-Meier survival analysis. This method does
not require corrections for zero cell counts, and thus it performs
well when events are rare (Deeks 1998). Throughout the analyses,
we took statistical significance at the two-sided 5% level (P <
0.05), presenting data as the estimated effect with 95% confidence
intervals. For the original review, we used SPSS version 14.0 and
Stata for all the analyses (SPSS 2006; Stata 2005), undertaking the
meta-analysis in Review Manager version 4.2. For this update, we
conducted analysis using Review Manager version 5.3 (RevMan
2014).
Our statistical analyses sought to include all randomised partici-
pants, using intention-to-treat. We relied on published data when
the IPD did not include the relevant outcomes. When combining
outcome data was not possible because of differences in the re-
porting of outcomes, we presented the data from individual stud-
ies in summary tables. For each comparison using published data
for dichotomous outcomes we calculated risk ratios using a fixed-
effect model to combine data. Comparison between health out-
comes was restricted by the different measurement tools used in
the included trials. Although planned, we did not attempt a direct
comparison of costs because the trials collected data on different
resources and used different methods to calculate costs.
Dealing with missing data
In two data sets contributing to the IPD meta-analysis (Davies
2000; Kalra 2000), some dates were missing for known events,
and so we gave the missing event a time at the midpoint between
randomisation and last follow-up, or as the midpoint between
follow-up times if these were known. For one trial where follow-
up was 90 days, we set the time to event as 45 days for three cases
in the admission avoidance hospital at home arm and for one case
in the control group where we knew death had occurred but we
did not have a date (Davies 2000). For the other trial, we gave
a time to event of 14 days if the participant was known to have
died some time between randomisation and one-month follow-
up, and at 59 days if they were known to have died between one
and three months’ follow-up (Kalra 2000).
Assessment of heterogeneity
We quantified heterogeneity by Cochran’s Q and the I2 statistic
(Cochran 1954), the latter quantifying the percentage of the total
variation across studies that is due to heterogeneity rather than
chance (Higgins 2003); smaller percentages suggest less observed
heterogeneity.
Assessment of reporting biases
We created one funnel plot, for mortality at six months’ follow-
up, recognising that when the number of trials is small these plots
are not necessarily indicative of publication bias.
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R E S U L T S
Description of studies
We identified 16 trials that randomised individual participants (N
= 1814), of which six were identified in this update. We invited 10
trialists to contribute data to the IPDmeta-analysis (Caplan 1999;
Davies 2000;Harris 2005; Kalra 2000;Mendoza 2009;Nicholson
2001; Ricauda 2004; Ricauda 2008; Tibaldi 2009;Wilson 1999),
of which six contributed data (n = 921/1206; 76%) (Davies 2000;
Harris 2005; Kalra 2000; Mendoza 2009; Ricauda 2004; Wilson
1999).We contacted the authors of a study published as a meeting
abstract for further information, but did not receive a reply (Andrei
2011, n = 45). We did not contact five trialists as their studies
included participants who were significantly different from the
remaining populations, for example populations with short-term
acute conditions or advanced dementia (Corwin 2005; Richards
2005; Talcott 2011; Tibaldi 2004; Vianello 2013). We used pub-
lished data when we did not have access to IPD. Follow-up times
varied across the different trials, ranging from1week to 12months.
Results of the search
For this update the search retrieved 1364 records, of which 1350
were ineligible.We obtained full texts for the remaining14 records,
seven of which fulfilled the inclusion criteria (six trials, seven
records), bringing the total number of trials included in the re-
view to 16 (Figure 1). We also identified two ongoing trials
(ISRCTN29082260; ISRCTN60477865).
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Figure 1. Study flow diagram.
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Included studies
Study populations
Three trials recruited participants with chronic obstructive pul-
monary disease (COPD) (Davies 2000; Nicholson 2001; Ricauda
2008), two trials recruited participants recovering from a moder-
ately severe stroke who were clinically stable (Kalra 2000; Ricauda
2004), and six trials recruited participants with an acute medical
condition who were mainly elderly (Andrei 2011; Caplan 1999;
Harris 2005; Mendoza 2009; Tibaldi 2009; Wilson 1999). There
was one trial each for participants with cellulitis (Corwin 2005),
community-acquired pneumonia (Richards 2005), fever and neu-
tropenia (Talcott 2011), frail elderly participants with dementia
(Tibaldi 2004), and neuromuscular disease (Vianello 2013). The
16 trials were conducted in seven countries: Australia (two trials),
Italy (five trials), New Zealand (three trials), Romania (one trial),
Spain (one trial), the UK (three trials), and the US (one trial).
Interventions
In 12 of the trials included in this review participants were ad-
mitted to hospital at home from the emergency room (Andrei
2011; Caplan 1999; Corwin 2005; Davies 2000; Mendoza 2009;
Nicholson 2001; Ricauda 2004; Ricauda 2008; Richards 2005;
Tibaldi 2004; Tibaldi 2009; Vianello 2013), in three directly from
the community following referral by their primary care physician
(Harris 2005; Kalra 2000; Wilson 1999), and in one from an
outpatient department (Talcott 2011). For participants allocated
to hospital at home, health care was provided by a hospital out-
reach team (Caplan 1999; Harris 2005; Mendoza 2009; Ricauda
2004; Ricauda 2008; Talcott 2011; Tibaldi 2004; Tibaldi 2009),
a mix of outreach and community staff (Davies 2000; Kalra 2000;
Nicholson 2001; Vianello 2013), or by the general practitioner
(GP) and community nursing staff (Corwin 2005; Richards 2005;
Wilson 1999). For one of the trials it was not clear who provided
care (Andrei 2011). In two trials, the intervention was provided
by Pegasus Health, an independent association of GPs (Corwin
2005; Richards 2005). One trial was a three-group comparison
of stroke unit care, inpatient stroke team, and hospital at home
(Kalra 2000); we selected the inpatient stroke team as the com-
parison group, as this was most similar to the comparator in the
other trials.
Physiotherapy care was described in seven of the interventions
(Harris 2005; Kalra 2000; Nicholson 2001; Ricauda 2004;
Ricauda 2008; Tibaldi 2004; Wilson 1999), and occupational
therapist care in four of the interventions (Harris 2005; Kalra
2000; Nicholson 2001; Wilson 1999). A social worker was part
of the hospital at home team in seven of the interventions (Davies
2000; Harris 2005; Kalra 2000; Ricauda 2004; Talcott 2011;
Tibaldi 2004; Wilson 1999), and a counsellor in one (Talcott
2011). Access to a speech therapist was described in three of the
interventions (Kalra 2000; Ricauda 2004;Wilson 1999).One trial
described access to a cultural link worker (Wilson 1999). The in-
tervention in one trial included the use of a portable ventilator;
a respiratory therapist made daily visits for the first three days of
home care, and district nurses and caregivers were trained in the
application of the device and on assisting with coughing (Vianello
2013). District nurses visited daily until recovery from the res-
piratory tract infection; participants also had telephone access to
pulmonary specialists (Vianello 2013).
Excluded studies
See theCharacteristics of excluded studies table.We excluded three
studies: one was a cross-over randomised controlled trial (King
2000), one a non-randomised comparison (Wade 1985), and in
the third study the intervention did not substitute for inpatient
care (Wolfe 2000).
Risk of bias in included studies
Allocation
In 11 studies concealment of allocation was adequate (Caplan
1999; Corwin 2005; Davies 2000; Harris 2005; Kalra 2000;
Mendoza 2009; Ricauda 2008; Richards 2005; Talcott 2011;
Tibaldi 2009; Wilson 1999) (Figure 2; Figure 3), and in eight
studies sequence generation was adequately described. (Caplan
1999; Harris 2005; Kalra 2000; Mendoza 2009; Ricauda 2004;
Ricauda 2008; Richards 2005; Talcott 2011)
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Blinding
All but one study used reliable measures of outcome (Vianello
2013), and four studies reported blinded assessment of outcome
(Kalra 2000; Ricauda 2004; Ricauda 2008; Tibaldi 2009). We
assessed 13 studies as at low risk of bias for the measurement of
objective outcomes, and seven at low risk of bias for the measure-
ment of subjective outcomes (Figure 3).
Incomplete outcome data
Most of the studies had a low risk of attrition bias, with seven
studies having an unclear risk (Andrei 2011; Mendoza 2009;
Nicholson 2001; Ricauda 2004; Richards 2005; Tibaldi 2004;
Tibaldi 2009).
Selective reporting
Six studies were at low risk of bias for selective reporting (Davies
2000; Harris 2005; Kalra 2000; Ricauda 2008; Tibaldi 2009;
Wilson 1999).
Effects of interventions
See: Summary of findings for the main comparison Admission
avoidance hospital at home compared with inpatient admission
for older people requiring admission to hospital
See Summary of findings for the main comparison for the main
comparison admission avoidance hospital at home compared with
inpatient admission for older people requiring admission to hos-
pital.
Mortality
We combined IPD, adjusted for age and sex, for mortality at three
months’ follow-up for five studies (risk ratio (RR) 0.77, 95% con-
fidence interval (CI) 0.54 to 1.09; P = 0.15; 833 participants;
moderate-certainty evidence) (Davies 2000; Harris 2005; Kalra
2000; Ricauda 2004; Wilson 1999) (Analysis 1.1); and combined
published data from three studies, Caplan 1999, Ricauda 2008,
and Tibaldi 2009, with data received from trialists for three stud-
ies, Kalra 2000, Ricauda 2004, and Wilson 1999, for mortality at
six months (RR 0.77, 95% CI 0.60 to 0.99; P = 0.04; 912 partic-
ipants; moderate-certainty evidence) (Analysis 1.2; Figure 4).
Figure 4. Funnel plot of admission avoidance hospital at home versus inpatient care, for mortality at 6
months’ follow-up (using data from trialists and published data from one study).
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Transfer (or readmission) to hospital
We analysed the effect of admission avoidance hospital at home
on hospital readmission or transfer at three months’ follow-up us-
ing data received from four trialists, Davies 2000, Harris 2005,
Mendoza 2009, and Wilson 1999, and published data from three
studies (Caplan 1999; Ricauda 2008; Tibaldi 2009). Results indi-
cated that admission avoidance hospital at homemaymake little to
no difference for hospital readmission or transfer (RR 0.98, 95%
CI 0.77 to 1.23; P = 0.84; 834 participants; moderate-certainty
evidence) (Analysis 1.4).
Functional status
Nine trials reported measures of functional ability, for which
higher scores indicate greater independence (see Analysis 1.5 for
specific details on the scales used). Caplan 1999 reported scores for
instrumental activities of daily living between admission and dis-
charge (meandifference (MD) -0.23, P =0.04), and theBarthel In-
dex (hospital at home (T): 0.37 (0.27), hospital (C): -0.04 (0.27)).
A trial that recruited participants with dementia reported that
fewer participants in the hospital at home group had problems
with sleep (difference 34%, P < 0.001), agitation and aggression
(difference 32.5%, P < 0.001), and feeding (difference 31%, P <
0.001) (Tibaldi 2004). One trial recruiting participants who had a
stroke reported the number of participants with a favourable out-
come measured by the Barthel (score of 15 to 20) at three months
(T: 106/145 (73%), C: 106/151 (70%), RR 0.96 (95% CI 0.83
to 1.11), P = 0.58) (Kalra 2000); and Ricauda 2004, which also
recruited participants with a stroke, reported activities of daily
living (scale 0 to 6) at six months (median (interquartile range
(IQR)), T: 4 (2 to 5), C: 4 (2 to 6); P = 0.57). Two trials recruiting
participants with COPD reported follow-up data: Ricauda 2008
reported activities of daily living at six months: T: 0.12 (standard
deviation (SD) 0.64), C: 0.08 (SD 0.73), P = 0.81, and Davies
2000 reported forced expiratory volume in 1 second (FEV1) at
three months’ follow-up (T: 41.5%, 95% CI 8.2% to 74.8%; C:
41.9%, 95% CI 6.2% to 77.6%). Two studies recruiting partici-
pants with heart failure reported change in activities of daily living
measured by the Barthel Index at six months’ follow-up (mean T:
-1.95 (SD 9.61), C: -0.30 (SD 10.12) (Tibaldi 2009); and at one
year (T: 4.0, 95% CI -0.9 to 8.9; C: 4.7, 95% CI -2.2 to 11.5; P =
0.21), adjusted for baseline differences (Mendoza 2009). Wilson
1999, which recruited older people with a mix of conditions, as-
sessed functional ability at three months using the Barthel Index
(median (IQR) T: 16 (13 to 19), C: 16 (12 to 20)) (Analysis 1.5).
Quality of life or self reported health status
Seven trials assessed health status or quality of life using different
measures (Analysis 1.6). One trial that recruited people with cel-
lulitis reported 36-Item Short Form Health Survey (SF-36) scores
at six days’ follow-up (physical component scale MD -5.2, 95%
CI -13.7 to 3.2; role physical scale MD 2.2, 95% CI -10.7 to
15.1; pain scale MD -3.8, 95% CI -10.6 to 3.0) (Corwin 2005).
A second trial measuring health status with the SF-36 reported
follow-up data at one year for the physical component scale (T:
3.6 (-0.5 to 7.7), C: 2.2 (-1.9 to 6.4); P = 0.47) and the mental
component scale (T: 4.0 (-0.9 to 8.9), C: 2.8 (-2.4 to 8.0); P =
0.38) (Mendoza 2009). One trial measured quality of life with the
SF-12 at six weeks’ follow-up and reported similar scores for each
group on the physical component (T: 42.2, C: 45.8; P = 0.18) and
mental component scale (T: 50.4, C: 51.0; P = 0.81) (Richards
2005). Two trials assessed quality of life using the Nottingham
Health Profile at six months’ follow-up (T: +1.09 (2.57) n = 48,
C: +0.18 (SD 1.94); P = 0.046) (Tibaldi 2009), and (T: 3.6 (SD
7.9), C: 0.8 (SD 4.5); P = 0.04) (Ricauda 2008). One trial assessed
a change from baseline in quality of life when a participant had a
health event using the EORTC QLQ-C30 (T: 0.58, C: 0.78, P =
0.05; emotional function hospital at home 3.27, hospital -6.94, P
= 0.04) (Talcott 2011). One trial reported median values at three
months’ follow-up for the Sickness Impact Profile (T: 24 (IQR 20
to 31), C: 26 (IQR 20 to 31); MD -2, 95% CI -4 to 4; P = 0.73)
and the EuroQol (T: 0.64, n = 73, C: 0.63, n = 96; MD 0.01,
95% CI -0.12 to 0.09; P = 0.94) (Wilson 1999).
Cognitive function and depression
Five trials measured cognitive function and depression (Analysis
1.7). One trial that recruited participants recovering from a stroke
reported that hospital at home may lead to lower scores on the
Geriatric Depression Scale (GDS) (lower scores = fewer symp-
toms) (MD 7 points, on a scale of 0 to 30, P < 0.001) (Ricauda
2004). A second trial, which recruited participants with COPD,
reported a greater improvement for those allocated to hospital at
home from baseline on the GDS at six months (T: -3.1 (SD 4.7),
C: 0.7 (SD 3.2), P < 0.0001) (Ricauda 2008). One trial that re-
cruited participants with acute chronic heart failure reported fewer
depressive symptoms at six months follow-up (measured by the
GDS) for those allocated to admission avoidance hospital at home
(mean change T: 1.48 (SD 1.86), C: 0.12 (SD 3.36); P = 0.02)
(Tibaldi 2009). Wilson 1999 reported median (IQR) scores for
the PhiladelphiaGeriatricMorale Scale at threemonths, with little
to no difference between groups (T: 37 (30 to 42), C: 37 (31 to
43); MD 0, 95% CI -4.1 to 4.1).
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Two trials used the mini-mental state examination to assess cog-
nitive functioning at six months’ follow-up and reported little to
no difference between groups (T: -0.4 (SD 4.0), C: -0.5 (SD 1.8);
P = 0.88) (Ricauda 2004); and (T: 0.07 (SD 1.38), C: 0.08 (SD
1.36); P = 0.97) (Tibaldi 2009). One trial that recruited partici-
pants with a mix of conditions reported cognitive function scores:
mean T: 0.43 (standard error of the mean (SEM) 0.12), C: 0.27
(SEM0.12), and that fewer people receiving hospital at home care
experienced short-term confusion during an episode of care (MD
-20.4%, 95% CI -32% to -9%) (Caplan 1999).
Clinical outcomes
One trial measured clinical complications, with fewer participants
allocated to hospital at home reporting bowel complications (dif-
ference -22.5%, 95% CI -34% to -10.8%) or urinary compli-
cations (difference -14.4%, 95% CI -25.4% to -3.3%) (Caplan
1999). In a trial recruiting participants with dementia, fewer par-
ticipants in the hospital at home group were prescribed antipsy-
chotic drugs at discharge (difference -14%, 95%CI -28%to0.3%)
(Tibaldi 2004). One trial that recruited people with cellulitis re-
ported risk of advancement of cellulitis (hazard ratio (HR) 0.98,
95%CI 0.73 to 1.32) (Corwin 2005), and one trial recruiting par-
ticipants with COPD reported that more participants were pre-
scribed an antibiotic if they were allocated to hospital at home
(difference 18%, 95% CI 1.4% to 34.6%) (Davies 2000). Talcott
2011 reported the difference in major complications during the
episode of care (difference 1%, 95% CI -10 to 13%) (Analysis
1.8).
Place of residence at follow-up (living in a residential setting)
Admission avoidance may reduce the likelihood of living in resi-
dential care, measured at discharge to six months’ follow-up (RR
0.35, 95% CI 0.22 to 0.57; P < 0.0001; I2 = 78%; 5 trials; low-
certainty evidence) (Kalra 2000; Ricauda 2004; Ricauda 2008;
Tibaldi 2004; Tibaldi 2009). We downgraded the certainty of ev-
idence due to the high level of statistical heterogeneity and impre-
cision (Analysis 1.9).
Patient satisfaction
Admission avoidance may increase patient satisfaction with the
health care received. Participants allocated to hospital at home
care reported higher levels of patient satisfaction across a range
of different conditions (5 studies; 646 participants; low-certainty
evidence). For participants with cellulitis, 27% (P < 0.0001) more
participants in the hospital at home group reported increased sat-
isfaction with their location of care compared with those admitted
to hospital (Corwin 2005), and 40% (P < 0.001) more partici-
pants with community-acquired pneumonia allocated to hospital
at home reported that they were happy with their care (Richards
2005). Two trials (recruitingmainly elderly participants with amix
of medical conditions) also reported increased levels of satisfaction
for those allocated to hospital at home care (median difference of
3 on a 0-to-18-point scale, P < 0.0001) (Wilson 1999), and aMD
of 0.9 on a 4-point scale (P < 0.0001) (Caplan 1999). However,
there was a low response rate for the control group in the latter
trial: 40% compared with 78% in the hospital at home group
(Caplan 1999). Some participants (6/101; 6%) refused hospital at
home care and were admitted to hospital, and a greater number
of participants allocated to hospital care (23/97; 24%) were not
admitted because of refusal by the participant, caregiver, or gen-
eral practitioner (Wilson 1999). One trial recruiting participants
with COPD reported the number assessing satisfaction with care
as very good or excellent (hospital at home 49/52 (94%), hospital
46/52 (88%); P = 0.83) (Ricauda 2008) (Analysis 1.10).
Caregiver outcomes
One trial reported that caregivers in the hospital at home grouphad
significantly higher levels of satisfaction compared with those in
the hospital group (difference -0.8 on a 4-point scale, P < 0.0001)
(Caplan 1999), although the response rate was 27% in the hospi-
tal group and 55% in the hospital at home group. A second trial
assessed caregiver satisfaction through semi-structured interviews;
caregivers reported that although hospital would potentially relieve
them from caring, the upheaval of visiting hospital and the ac-
companying anxiety was a less satisfactory option (Wilson 1999).
One trial recruiting participants with COPD reported change in
relatives’ stress at six months (mean scores (SD) T: 4.6 (5.6), C:
2.6 (6.1); P = 0.16) (Ricauda 2008) (Analysis 1.11).
Health professionals’ views
One trial evaluated general practitioners’ satisfaction with the ser-
vice (T: 1.17, C: 1.8, score of 1 to 4, with high score being ex-
cellent, low score poor); the response rate was poor: 63% in the
hospital at home group and 37% in the control group (Caplan
1999) (Analysis 1.12).
Length of stay in hospital and hospital at home
Seven trials reported the effect of admission avoidance hospital at
home on length of hospital stay and hospital at home, with dif-
fering results (Analysis 1.13). Length of stay varied from a mean
reduction of -8.09 days (95%CI -14.34 to -1.85) in a trial recruit-
ing older people with varied health problems (Wilson 1999), to a
mean increase of 15.90 days (95% CI 8.10 to 23.70) in a study
that recruited patients recovering from a stroke (Ricauda 2004).
One trial recruiting participants that were recovering from a stroke
reported that 51 out of 153 (33%) of participants allocated to
hospital at home received inpatient care within two weeks of ran-
domisation, with a mean length of stay of 49 days; this exceeded
the mean length of stay for those allocated to an inpatient hospital
stroke team by 17 days (95% CI 7.9 to 25.3) (Kalra 2000).
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Cost
Two trials reported a full evaluation of healthcare resources and
costs (Patel 2004 for Kalra 2000;Wilson 1999); one of these trials
included informal-care costs (Patel 2004 for Kalra 2000). Admis-
sion avoidance hospital at home may slightly decrease treatment
costs, although this benefit is offset when the costs of informal care
are considered (287 participants, low-certainty evidence).
Elderly participants with a medical condition
One trial reported a cost minimisation analysis (Wilson 1999),
finding an initial increase in the mean cost per day for hospital at
home (differenceGBP 99.71, P < 0.001) and little or no difference
in cost at three months’ follow-up (GBP -210.9, 95% CI GBP -
1025 to GBP 635.47). When participants refusing their allocated
place of care (T: n = 6/101, C: n = 23/97) were removed from the
analysis, there was a reduction in costs for those receiving hospital
at home for the initial episode of care (difference GBP -1070.53,
95% CI GBP -1843.2 to GBP -245.73) and at three months’
follow-up (difference GBP -1063.45, 95%CIGBP -2043 to GBP
-162.7). The difference in mean cost per day between hospital at
home and hospital care was reduced, although hospital at home
care remainedmore costly per day (GBP206.68 versusGBP133.7,
MD GBP 72.98, P < 0.001).
Another trial, recruiting mainly elderly participants with a mix of
conditions, examined health service costs (Board 2000 secondary
publication to Caplan 1999), using average costs and reported
reduced health service costs for the intervention group (T: AUD
1764 (SD AUD 1253), C: AUD 3775 (SD AUD 2496) for an
episode of care, MD per episode AUD -2011) and cost per day (T:
AUD 191 (SD AUD 58), C: AUD 484 (SD AUD 67.23); MD
AUD293). The costs of the nurse co-ordinator andhospital doctor
involved were excluded from this analysis (see Analysis 1.14.1).
Mendoza 2009 reported the mean (SD) cost at one-year follow-
up (T: EUR 2541 (1334), C: EUR 4502 (2153); difference EUR
1961, P < 0.001).
Participants recovering from a stroke
A trial recruiting participants recovering from a stroke compared
stroke unit care, inpatient stroke team care, and hospital at home.
In terms of immediate care, hospital at home care was less costly
than inpatient stroke team care (MD GBP -2096, 95% CI GBP -
3272 to GBP -920). The inclusion of costs of informal care, based
on the minimum wage, resulted in a MD of GBP -2216 (95% CI
GBP -4771 to GBP 339) (Patel 2004 for Kalra 2000) (Analysis
1.14). In another trial recruiting participants with a stroke, a small
reduction inmean cost per patient was reported for those allocated
to hospital at home (USD 6413.5 versus USD 6504.8) (Ricauda
2004), which translated to a lower cost per day for hospital at
home of USD 112.00 (USD 163.0, SD 20.5 versus USD 275.6,
SD 27.7; P < 0.001).
COPD and community-acquired pneumonia
One trial recruiting participants with COPD reported a lower
mean health service cost for participants allocated to hospital at
home; hospital costs were based on an average DRG (a diagnostic-
related group categorised by resource use) cost per bed day (cost
per episodeMDGBP -1798, P < 0.01) (Nicholson 2001). Another
trial recruiting participants with community-acquired pneumo-
nia, again using DRG costs for the control and actual resource use
for costing the intervention, reported a reduced cost for those allo-
cated to hospital at home (mean cost per patient T: NZD 1157.9,
C: NZD 1556.28) (Richards 2005). Ricauda 2008 reported the
total mean cost per patient (T: USD 1175.9, C: USD 1390.9, P =
0.38) and the total mean cost per day (T: USD 101.4 (SD 61.3),
C: USD 151.7 (SD 96.4)).
Use of other health services and informal care
Davies 2000 reported an increase in referrals for social support for
participants with COPD who were allocated to hospital at home.
This occurred during the time theywere receiving hospital at home
or when the control group had been discharged from hospital
(24% versus 6%, difference 18%, 95% CI 7.3% to 28.6%) (
Analysis 1.14.2). One trial recruiting participants recovering from
a stroke reported that 71% (100/140) of those allocated to hospital
at home received informal care, compared with 67% (98/147)
receiving care from the inpatient stroke team (Patel 2004). This
translated into 979 hours (SD 1749) versus 846 hours (SD 1549)
of care over a 12-month period (Analysis 1.14.3).
D I S C U S S I O N
Summary of main results
Admission avoidance hospital at home, with the option of transfer
to hospital, may provide an effective alternative to inpatient care
for a select group of elderly patients requiring hospital admission.
Admission avoidance hospital at home probably makes little or
no difference to the risk of death at six months’ follow-up or
transfer to hospital (moderate-certainty evidence); it may increase
the likelihood of living at home (low-certainty evidence). The
increased satisfaction reported by patients allocated to hospital at
home (low-certainty evidence) must be balanced against the lack
of evidence on the views of caregivers. Interviews with patients
reveal that the most-valued aspects of hospital at home care are
the quality of communication and personal care received (Wilson
1999).
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The total costs for the initial episode of care were estimated at 3
and 12 months after randomisation. We were not able to combine
cost data due to the different ways costs had been calculated, and
only two trials conducted a full economic evaluation (Jones 1999
for Wilson 1999; Patel 2004 for Kalra 2000). Hospital at home
may decrease treatment costs slightly when compared with admis-
sion to an acute hospital ward (low-certainty evidence). However,
caregiver costs may offset this difference.
There was some variation in the way the admission avoidance
hospital at home schemes operated. Admission avoidance hospi-
tal at home schemes admitted patients directly from the com-
munity (Harris 2005; Kalra 2000; Vianello 2013; Wilson 1999),
outpatients (Talcott 2011), and from an accident and emergency
department (Andrei 2011; Caplan 1999; Corwin 2005; Davies
2000; Mendoza 2009; Nicholson 2001; Ricauda 2004; Ricauda
2008; Richards 2005; Tibaldi 2004; Tibaldi 2009). Three trials
evaluated interventions where the patient could be living alone,
and five trials required a caregiver to be either living with the pa-
tient or nearby. Nonetheless, there were some important common
features, which included care being co-ordinated in each of the
schemes by a multidisciplinary team; the provision of 24-hour
cover if required, with access to a doctor; and a safe home envi-
ronment.
Overall completeness and applicability of
evidence
The evidence indicates that admission avoidance hospital at home
can provide an effective alternative to inpatient care for a select
group of patients requiring hospital admission. However, deter-
mining the type of patients who are most likely to benefit is not
simple. The majority of the included trials recruited participants
who were elderly with a medical event, including stroke, COPD,
and heart failure, that required admission to hospital. Their aver-
age age ranged from 70 to over 80 years. The patients opting to
participate in the trials may prefer treatment at home, this may
be why high levels of satisfaction are reported for those receiving
healthcare at home. All trials but one, Andrei 2011, were con-
ducted in high-income countries.
Half of the trials excluded patients who did not have contin-
uous family support (Caplan 1999; Mendoza 2009; Ricauda
2004; Ricauda 2008; Richards 2005; Tibaldi 2004; Tibaldi 2009;
Vianello 2013). Although none of the included trials specifically
looked into the socioeconomic characteristics of the excluded pa-
tients, it has been suggested that more disadvantaged areas have
a higher percentage of informal caregivers (Young 2005). Three
trials included participants from ethnic minorities, ranging from
14% to 20% of all recruited participants (Corwin 2005; Richards
2005; Talcott 2011); the authors did not report subgroup analysis
for these participants.
Quality of the evidence
Whilewe assessed the overall risk of bias as low, the studies included
in this review were small, with the largest study recruiting 197
participants who contributed to the analysis. The meta-analysis
for the main outcome included a subgroup of six trials recruiting
participants with similar conditions (older patients with a mix of
medical conditions) to limit heterogeneity. A further concern is
the role of chance and the fact that risk of publication bias cannot
be ruled out.
Potential biases in the review process
We limited publication bias by conducting an extensive search that
included different databases of published articles and sources of
unpublished literature. Over the last 20 years we have established
an international network of people working in this field who alert
us to new randomised controlled trials. Two people screened all
search results in order to reduce the risk of missing a study for
inclusion, and the review authors discussed studies for possible
inclusion to check that the inclusion criteria had been consistently
applied.
Agreements and disagreements with other
studies or reviews
Other reviews have analysed the effect of hospital at home schemes
for patients with specific conditions, such as COPD and heart fail-
ure (Jeppesen 2012; Qaddoura 2015). For patients with COPD,
it was reported that hospital at home reduced the number of read-
missions when compared with hospital care, with inconclusive ev-
idence for mortality, health-related quality of life, cost, and clini-
cal outcomes (Jeppesen 2012). The findings of a review of a small
number of studies that specifically recruited patients with heart
failure indicated a slight increase of time to readmission, improved
health-related quality of life, and reduced index costs, with limited
evidence for mortality for those allocated to hospital at home. The
authors judged these studies to be of modest quality (Qaddoura
2015).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Problems can arise when comparisons are made between coun-
tries. The 16 trials included in this review came from Australia,
Italy, New Zealand, Romania, Spain, the UK, and the US. Al-
though the health systems in these countries vary with respect to
the way healthcare financing is structured, the policy objectives are
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the same, with admission avoidance hospital at home being pro-
vided to control costs and reduce demand for inpatient hospital
beds (Naik 2006). The level of existing primary care in a country,
and the enthusiasm of local clinicians and healthcare managers,
may determine the degree to which admission avoidance hospi-
tal at home operates as an outreach model or is run by supple-
menting existing primary care services. The way health care for
the control group is organised will have an impact on outcome.
The entry criteria required patients to be clinically stable and not
requiring specialist diagnostic investigation or emergency inter-
ventions. Patients eligible for the trials included in this review did
not include those whose condition was so severe that death was
an expected outcome. Furthermore, patients whose condition un-
expectedly deteriorated, or who could no longer be managed at
home, had access to hospital admission. Interestingly, fewer be-
havioural problems were reported for those allocated to admission
avoidance hospital at home in the trial recruiting patients with
dementia, despite them experiencing serious cognitive and func-
tional decline (Tibaldi 2004).
Although admission avoidance hospital at home provides an al-
ternative to inpatient admission for some patients, the volume of
such patients recruited to the included trials was low, and some of
these patients will require access to hospital services, thus making
the closure of a ward or hospital in favour of hospital at home
an unrealistic option. Furthermore, the effectiveness of admission
avoidance hospital at home may be reduced if hospital admission
incorporates aspects of care known to be effective for these groups
of patients, such as stroke unit care or comprehensive geriatric as-
sessment (Stroke Unit Trialist; Stuck 1993).
It should be noted that admission avoidance hospital at home does
not totally substitute for hospital, in that admission to hospital
remains an option if required. One trial recruiting participants
recovering from a stroke reported that 51 out of 153 (33%) of
the patients allocated to hospital at home received inpatient care
within two weeks of randomisation (Kalra 2000). In another trial,
a small proportion (6 out of 101; 6%) refused hospital at home
care and were admitted to hospital (Wilson 1999).
Implications for research
Over the last 15 years the randomised evidence has grown from
1 to 16 trials, despite the practical difficulties of conducting ran-
domised controlled trials of service innovations, which is encour-
aging. However, the continuing lack of functional outcome mea-
sures, failure to record place of residence at follow-up, and absence
of economic evaluations are disappointing. Future research of ad-
mission avoidance hospital at home should continue to measure
mortality, readmission (with particular attention to the transfer
of patients between admission avoidance hospital at home and
inpatient care), and place of residence at follow-up. In addition,
clinical and dependency data of recruited patients should be col-
lected using standardised measures to facilitate the application of
evidence. Trials should also include a formal, planned economic
analysis using costs that are sensitive to the different resources used
during an episode of care. Comparisons with other ways of or-
ganising inpatient care, for example incorporating aspects of case
management and comprehensive assessment, would also improve
the evidence supporting decisions about how services should be
organised to maximise health outcomes. The effect of the inter-
vention for patient groups considered to be at higher risk of hos-
pital admission should also be considered. Some of the factors to
take into account are age, social circumstances, and comorbidities.
Finally, the role of advanced portable medical devices and com-
munication technologies in admission avoidance hospital at home
could be explored in pilot studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andrei 2011
Methods Parallel RCT
Participants Setting: Romania
People with chronic heart failure that had deteriorated at a minimum of 1 week prior
to recruitment. Number of participants in each group was not reported, a total of 45
participants recruited
Interventions Admission avoidance hospital at home; the first 48 hours of treatment was in the emer-
gency department
Outcomes Mortality, biological measures, and cost
Notes Follow-up at 1, 3, 6, and 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The study was published as an abstract, details not reported
Allocation concealment (selection bias) Unclear risk The study was published as an abstract, details not reported
Baseline outcome measurements (selection
bias)
Unclear risk The study was published as an abstract, details not reported
Baseline characteristics (selection bias) Unclear risk The study was published as an abstract, details not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Not reported
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Methods not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The study was published as an abstract, details not reported
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Andrei 2011 (Continued)
Selective reporting (reporting bias) Unclear risk The study was published as an abstract, details not reported
Caplan 1999
Methods Parallel RCT
Participants Setting: Australia
Range of acute conditions requiring admission to hospital; participants recruited from
casualty
Number recruited: hospital at home = 51; hospital = 49
Interventions Hospital community outreach team
Type of service: Hospital community outreach team. Clinical responsibility by GP or
hospital doctor if GP declined
Outcomes Functional status,mental status, clinical complications, patient and caregiver satisfaction,
GP views
Notes Follow-up: 1 and 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers, stratified by partici-
pant’s residence and if they had a deep vein thrombosis
Allocation concealment (selection bias) Low risk Sealed envelope
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
functional and mental status, and diagnoses; no relevant differ-
ences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of treatment and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Unclear risk for functional status, mental status, clinical com-
plications, patient and caregiver satisfaction, GP view
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality, readmission
26Admission avoidance hospital at home (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Caplan 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up reported
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Corwin 2005
Methods Parallel RCT
Participants Setting: New Zealand
Patients with cellulitis
Number recruited: treatment: 98, control: 96
Ages mean (SD): T: 54.6 (20.6), C: 48.4 (19)
European: T: 77/98 (79%), C: 78/96 (81%)
Maori: T: 10/98 (10%), C: 5/96 (5%)
Pacific: T: 2/98 (2%), C: 1/96 (1%)
Other: T: 9/98 (9%), C: 13/96 (12%)
Interventions Hospital at home admission avoidance from the emergency department. Run by Pegasus
Health, an independent practitioner’s association for 230 GPs in Christchurch, New
Zealand.
Care provided by GP and community care nursing staff.
Patients required IV antibiotics for cellulitis
Outcomes Advancement of cellulitis, readmission, days on IV antibiotics, functional outcomes (SF-
36), patient satisfaction
Notes Follow up: 3 and 6 days
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation list produced by SAS code
Allocation concealment (selection bias) Low risk Telephone randomisation service
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
functional outcomes; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of treatment and control groups are re-
ported and similar for main characteristics
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
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Corwin 2005 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Unclear risk for pain, functional and physical health (SF-36),
and satisfaction
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for advancement of cellulitis
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 from each group excluded at follow-up
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Davies 2000
Methods Parallel RCT
Participants Setting: UK
Patients with chronic obstructive airways disease
Number recruited: hospital at home: 100, hospital: 50
Interventions Hospital at home
Type of service: admission avoidance from accident and emergency department. Care
provided by outreach specialist nurses and GP and community nurses if required
Outcomes Respiratory function, readmission, quality of life
Notes Few details on measure of quality of life
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Ratio of 2:1 (hospital at home: hospital)
Allocation concealment (selection bias) Low risk Opaque, sealed envelopes
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
respiratory function; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of participants and personnel not possible
Hospital readmission was a primary outcome, with decision to
admit made by hospital staff
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Davies 2000 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk A small group of participants completed the St George’s Respi-
ratory Questionnaire
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for admission to hospital, changes in FEV1 score
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up: hospital at home: 7/100; hospital: 5/50
Selective reporting (reporting bias) Low risk All outcomes reported (received trial data set)
Harris 2005
Methods Parallel RCT
Participants Setting: New Zealand
Patients had a broad range of diagnoses: fractures (28%);miscellaneousmedical problems
(18%); respiratory problems (16%); stroke and neurological diagnoses (14%); falls and
injuries (11%); cardiac diagnoses (8%); and rehabilitation and other problems (5%)
Number recruited: hospital at home: 39, hospital: 37
Interventions Operated as a hospital outreach programme under the management of Auckland Hos-
pital from the emergency department or acute assessment ward. A nurse-led multidisci-
plinary team (physiotherapy, occupational therapy, social work) co-ordinated care and
rehabilitation for the patient within the patient’s own home. There was a daily nursing
review. Clinical responsibility was held by a dedicated hospital at home registrar, a con-
sultant geriatrician, and in some cases the patient’s GP, with 24-hour on-call medical
cover. The service provided care 7 days a week with 10 hours nursing care a day available,
and a 24-hour live-in home caregiver if required. There was a daily nursing review, and
a discharge hand over to ongoing support services
Outcomes Activities of daily living, cognitive function, instrumental activities of daily living
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation service
Allocation concealment (selection bias) Low risk Telephone randomisation service
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Harris 2005 (Continued)
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
activities of daily living, instrumental activities of daily living,
and cognitive functioning; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of participants and personnel not possible
Research staff did not make decision to admit to hospital
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Trained researchers not involved in patient care assessed partic-
ipants for functional independence (FIM), cognitive function
(MMSE), and instrumental activities of daily living (OARS)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality, readmission, and measurement and val-
uation of costs
Incomplete outcome data (attrition bias)
All outcomes
Low risk Participants withdrawing: hospital at home: 4/143; hospital: 10/
124
Selective reporting (reporting bias) Low risk All outcomes reported (received trial data set)
Kalra 2000
Methods Parallel RCT
Participants Setting: UK
Patients recovering from a moderately severe stroke
Number recruited: hospital at home: 153; stroke unit care: 152; hospital care: 152
Median age (IQR): T: 75 (72 to 84), C: 77.7 (67 to 83)
Living alone: T: 50/148 (34%), C: 50/149 (34%)
Interventions Hospital outreach admission avoidance multidisciplinary with joint care from commu-
nity services
Outcomes Mortality, institutionalisation, level of independence, activities of daily living, treatment
inputs, readmission, hospital length of stay, cost
Notes Follow-up: 3, 6, and 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
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Kalra 2000 (Continued)
Random sequence generation (selection
bias)
Low risk Block randomisation, computer-generated random numbers
Allocation concealment (selection bias) Low risk Telephone randomisation
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
level of independence and activities of daily living; no relevant
differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of participants and personnel not possible
Primary outcome: death
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk A trained researcher, independent of the health care provided
and unaware of treatment allocation, assessed functional status
(Barthel and Rankin scale)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality, institutionalisation, resource use and cost
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up: hospital at home: 9/144; hospital: 3/152
Selective reporting (reporting bias) Low risk All outcomes reported (received trial data set)
Mendoza 2009
Methods Parallel RCT
Participants Setting: Spain
Patients in A&E with acute decompensation of chronic heart failure
Inclusion criteria: > 65 years of age, with heart failure for 12 at leastmonths prior to study,
NYHA functional class II or III prior to acute episode, all-day supervision available,
telephone, < 10k from hospital
Age > 65 years, mean age 79. 29% female in hospital arm, 51% female in hospital at
home arm
Number recruited (betweenMay 2006 andMarch 2007): hospital at home: 37; hospital:
34
Interventions Admission avoidance hospital at home, patients admitted from the emergency depart-
ments, hospital outreach model. Hospital at home nurse visited within 12 to 24 hours
of admission to hospital at home and then daily visits. Care available between 8 am and
9 pm; patients called emergency services outside these hours. Hospital specialist visited
daily or every other day, depending on the patient’s condition
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Mendoza 2009 (Continued)
Control group: admitted to hospital
Outcomes Mortality, readmission, functional status, general health status, length of stay, costs
Notes Follow-up 1 year after discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation described as “externally generated sequence.”
Allocation concealment (selection bias) Low risk Random sequence hidden from the physician until patient had
consented to participate
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
functional status and general health status; no relevant differ-
ences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk A trained researcher, independent of the health care provided,
assessed functional status (Barthel Index), health-related quality
of life (SF-36)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for death, readmission
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 9 of 80 did not complete the study (2 in hospital at home group,
7 in hospital group)
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Nicholson 2001
Methods Parallel RCT
Participants Setting: Australia
Patients with COPD
Inclusion criteria: age > 45 years, COPD, current or ex-smoker, FEV1 < 60% predicted,
admission requested by GP or OPD clinic staff or ED staff, telephone at home
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Nicholson 2001 (Continued)
Number recruited: hospital at home: 13; hospital: 12
Interventions Hospital at home (discharge from emergency department)
Patients retained in patient status and received clinical supervision from hospital spe-
cialist, and hospital had legal and financial responsibility; also received care from GP,
community nursing, and domiciliary care. Hospital medical staff provided 24-hour tele-
phone support
Outcomes Cost to the health service
Notes Follow-up: duration of care in hospital at home or inpatient care
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random sequence generation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Baseline outcome measurements (selection
bias)
Unclear risk Baseline outcome measurements not reported
Baseline characteristics (selection bias) Unclear risk Baseline characteristics of the study and control groups not re-
ported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk None reported
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for resource use and cost
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to allocate low or high risk
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
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Ricauda 2004
Methods Parallel RCT
Participants Setting: Italy
Patients recovering from a stroke
Eligibility criteria: patients admitted tohospital within 24 hours of the onset of symptoms
and evaluated for at least 24 hours
Age (IQR): 76 to 88, median 82
Number recruited: hospital at home: 60; hospital: 60
Interventions Hospital outreach admission avoidance.
24-hour care available multidisciplinary team: physiotherapist, occupational therapist,
nursing, hospital geriatrician, social worker, speech therapist, psychologist
Outcomes Length of treatment, mortality, activities of daily living, functional impairment, depres-
sion, costs
Notes Follow-up: 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomisation
Allocation concealment (selection bias) Unclear risk Not described
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
activities of daily living, functional impairment, and depression;
no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Outcomes assessor blinded to the study allocation, and used
validated measures of outcome
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Outcomes assessor blinded to the study allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Withdrawals not reported
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Ricauda 2004 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Ricauda 2008
Methods Parallel RCT
Participants Setting: Italy
Patients requiring acute hospitalisation for acute exacerbation of COPD; care supervision
at home; telephone connection; living in the catchment area; family or social support
Age (SD): T: 80.1 (3.2), C: 79.2 (3.1)
Number recruited: hospital at home: 52; inpatient: 52
Interventions Physician-led admission avoidance hospital outreach service; geriatric home hospitalisa-
tion service (GHHS) of a regional hospital
The home care program emphasised patient and caregiver education about the disease,
advice about smoking cessation, nutrition, management of activities of daily living and
energy conservation, understanding and use of drugs, health maintenance, and early
recognition of triggers of exacerbation that required medical intervention. In the first
days after admission to GHHS, physicians and nurses visited each patient at home daily,
then daily visits by the nurse and visits by the doctor every 2 to 3 days or less. Blood
tests, electrocardiogram, spirometry, pulse oximetry, oxygen, IV fluids, antimicrobials
and other medications, blood transfusions, surgical treatment for pressure ulcers were
available
Control group: inpatient hospital care
Outcomes Mortality, readmission, health status, satisfaction, residential care, length of stay, resource
use and cost, caregiver outcomes
Notes Follow-up: 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk The project manager randomly allocated participants using a
numbered set of sealed envelopes
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
health status; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
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Ricauda 2008 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Data collected by independent postgraduate physicians who
were not involved in the care of patients or the research team
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Outcomes assessed by a postgraduate doctor not involved with
delivery of health care, and blinded to the study allocation
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Outcomes assessed by a postgraduate doctor not involved with
delivery of health care, and blinded to the study allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk Standard set of outcomes reported
Richards 2005
Methods Parallel RCT
Participants Setting: New Zealand
Patients with community-acquired pneumonia
Age: T: 50.1, C: 49.8
Number recruited: hospital at home: 24; hospital: 25
Interventions Hospital at home: admission avoidance from emergency room. Run by Pegasus Health,
an independent practitioner’s association for 230 GPs in Christchurch, New Zealand.
Care provided by GP and community care nursing staff
Outcomes Median number of days to discharge, days of IV antibiotics, functional outcomes, mor-
tality, readmission, patient satisfaction, costs
Notes Follow-up: 2 and 6 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk Telephone randomisation
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
functional outcomes; no relevant differences found
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Richards 2005 (Continued)
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Patient-rated symptoms, satisfaction
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Days on IV antibiotics, admissions extracted from clinical
records
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 6 exclusions after randomisation, no loss to follow-up
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Talcott 2011
Methods Parallel RCT
Participants Setting: US
Participants: outpatients with postchemotherapy febrile neutropenia and assessed as low
risk
Age 20 to 81 years, median 47 years
Number recruited: hospital at home: 47; inpatient: 66
Interventions Admission avoidance hospital at home, patients recruited from outpatient clinic. Pro-
vided by commercial home care provider, daily visits by a home care nurse who followed
a protocol/standard checklist and contacted the primary care physician if there were ab-
normal findings. Daily blood tests. 24-hour care available. Hospital specialist examined
the patient 2 to 4 days following discharge and then at least weekly. Home IV available
Control group received care in oncology units in general hospitals
Outcomes Major medical complications, readmission to hospital, quality of life
Notes Folllow-up time for each episode was the resolution of fever, neutropenia, and any
complications arising during the episode. Quality-of-life data were collected at the time
of consent to join the study and as soon as possible after the resolution of the episode
Risk of bias
Bias Authors’ judgement Support for judgement
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Talcott 2011 (Continued)
Random sequence generation (selection
bias)
Low risk Computer-generated blocks of random numbers stratified by
colony-stimulating factors, institution, and whether random as-
signment occurred on weekends, holidays, or after hours
Allocation concealment (selection bias) Low risk Sealed envelopes
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
clinical characteristics and quality of life; no relevant differences
found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar for all main characteristics
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Any medical event requiring urgent diagnostic or therapeutic
intervention. Predefined complications included systemic hy-
potension (systolic blood pressure > 90 mmHg), respiratory fail-
ure (partial pressure of oxygen < 60 torr adjusted for hyperven-
tilation)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Predefined medical complications using blinded review
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality and cost
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up, 5 withdrawn/excluded (3
withdrew consent, 2 excluded as neutropenia had resolved at
recruitment)
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Tibaldi 2004
Methods Parallel RCT
Participants Setting: Italy
Patients: elderly with advanced dementia
Mean age (SD): T: 82.9 (7.9), C: 84.1 (7.5)
Number recruited: hospital at home: 56; inpatient: 53
Interventions Hospital at home run by S. Giovanni Battista Hospital, Turin, Italy: geriatric home
hospitalisation service, patients referred from emergency department
24-hour-a-day care available, home nursing multidisciplinary care, rapid access to equip-
ment
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Tibaldi 2004 (Continued)
Outcomes Behavioural disturbances, number of patients treated with antipsychotic drugs on ad-
mission and on discharge, mortality, length of stay, place of discharge (home or to a
nursing home)
Notes Follow-up: to discharge from service
4 admitted from hospital at home to hospital for new medical problems
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random sequence generation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
cognitive status, severity of disease, and activities of daily living;
no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Assessment method not reported
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Low risk for mortality
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Withdrawals not reported
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Tibaldi 2009
Methods Parallel RCT
Participants Setting: Italy
People with acute decompensation of chronic heart failure recruited within 12 to 24
hours of admission to the emergency department. Care supervision possible at home,
telephone at home, need for IV infusions, living in catchment area, at least 1 previous
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Tibaldi 2009 (Continued)
admission for chronic heart failure
Age: 75 years and over, mean age 81
Number recruited: hospital at home: 48; hospital: 53
Interventions Admission avoidance hospital at home, hospital outreach (hospital maintains legal and
financial responsibility); 24-hour care available 7 days a week; 4 specialist geriatricians,
home care nurses, physiotherapist, social worker, counsellor, IV infusions available
Control group: admission to San Giovanni Battista Hospital, Turin, Italy
Outcomes Mortality, readmission, length of stay, residential care, health status, psychological well-
being
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Computer-generated random sequence
Allocation concealment (selection bias) Low risk Numbered, sealed envelopes
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
health status and psychological well-being; no relevant differ-
ences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Outcomes assessed by a postgraduate doctor not involved with
delivery of health care, and blinded to the study allocation
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Outcomes assessed by a postgraduate doctor not involved with
delivery of health care, and blinded to the study allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 4% loss to follow-up
Selective reporting (reporting bias) Low risk Standard set of outcomes reported
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Vianello 2013
Methods Parallel RCT
Participants Setting: Italy
Patients with neuromuscular disease and who had an acute respiratory tract infection
and required hospital admission; recruited between January 2009 and December 2011
Number recruited: hospital at home: 26; inpatient hospital: 27
Interventions The use of a portable ventilator; a respiratory therapist made daily visits for the first 3
days of home care, and district nurses and caregivers were trained in the application of
the device and on assisting with coughing. District nurses visited daily until recovery
from the respiratory tract infection, participants also had telephone access to pulmonary
specialists
Outcomes Recovery from exacerbation defined as relief of respiratory distress and return of SpO2
level
Notes 3 months’ follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Unclear risk Not reported
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
respiratory distress and SpO2 level; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not possible
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Subjective outcomes not reported
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality, need for intubation, and cost
Incomplete outcome data (attrition bias)
All outcomes
Low risk Follow-up data reported in Table 3, page 2066; the authors did
not report loss to follow-up
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Vianello 2013 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to allocate low or high risk
Wilson 1999
Methods Parallel RCT
Participants Setting: UK
Patients with a mix of conditions (majority elderly) referred by GP to Bed Bureau
Number recruited: hospital at home: 102; inpatient: 97
Interventions Hospital at home (admission avoidance)
Type of service: multidisciplinary team (nurses, therapy, generic health workers, cultural
link worker)
Maximum of 5 patients at a time
Control group: inpatient hospital care
Outcomes Mortality, readmission, functional status, quality of life, patient satisfaction
Notes Follow-up: 3 days, 2 weeks, 3 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation
Allocation concealment (selection bias) Low risk Consecutively numbered, sealed envelopes
Baseline outcome measurements (selection
bias)
Low risk Baseline outcome measurements done prior to intervention for
functional status andquality of life; no relevant differences found
Baseline characteristics (selection bias) Low risk Baseline characteristics of the study and control groups are re-
ported and are similar
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Outcome assessments by independent research staff, decision to
admit made by hospital staff, not research team
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Low risk for health status (Sickness Impact Profile 68), cogni-
tive function (Clifton Assessment Procedures for the Elderly),
functional status (Barthel Index), and quality of life (EuroQol)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Low risk for mortality, readmission, resource use and cost
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Wilson 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up: hospital at home: 8/87; hospital: 5/80
Selective reporting (reporting bias) Low risk All outcomes reported (received trial data set)
A&E: accident & emergency department
C: control
COPD: chronic obstructive pulmonary disease
ED: emergency department
FEV1: forced expiratory volume at 1 second
FIM: Functional Independence Measure
GHHS: geriatric home hospitalisation service
GP: general practitioner
IQR: interquartile range
IV: intravenous
MMSE: mini-mental state examination
NYHA: New York Heart Association
OARS: Older Americans’ Resources and Services
OPD: outpatient department
RCT: randomised controlled trial
SD: standard deviation
SF-12: 12-Item Short Form Health Survey
SF-36: 36-Item Short Form Health Survey
T: treatment
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
King 2000 Cross-over randomised controlled trial evaluating chemotherapy provided in a home setting with an outpatient clinic
setting
Wade 1985 Clinical controlled trial
Compared 2 districts, 1 with a domiciliary stroke service and 1 without
Wolfe 2000 Intervention does not substitute for inpatient care
43Admission avoidance hospital at home (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of ongoing studies [ordered by study ID]
ISRCTN29082260
Trial name or title Randomised controlled trial of hospital at home compared to standard inpatient management of patients with
an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), triaged for hospital admission by
Accident and Emergency and with low mortality risk according to the novel DECAF score (HOT DECAF)
Methods Parallel RCT; economic evaluation; qualitative interviews
Participants Adults >= 35 years admitted with acute exacerbation of COPD and assessed as low risk by a clinical scoring
system
Interventions Patients allocated tohospital at homewill remainunder the care of the hospital team,with 24/7on-call support.
Home treatment will comprise of twice daily respiratory specialist nurse visits supervised by a respiratory
consultant, with additional input from physiotherapy, occupational therapy, and formal social care as required
Comparison: usual care
Outcomes Main outcomes: health and social care costs over 90 days (non-inferiority analysis)
Other outcomes: survival; all-cause and respiratory readmission rates; bed days over a) acute period of care,
and b) postdischarge to 90 days; caregiver and patient preference; COPD exacerbations; unplanned health
resource use; hospital anxiety and depression score; quality of life; caregiver burden; perceptions of health care
of patients and their caregivers and health professionals with regards to the use of the clinical score for group
allocation
Starting date 28 April 2014
Contact information
Notes ISRCTN29082260
ISRCTN60477865
Trial name or title A multi-centre randomised controlled trial to compare the effectiveness of admission avoidance hospital
at home with comprehensive geriatric assessment vs. inpatient comprehensive geriatric assessment on the
number of frail older people ‘living at home’ (RCT of comprehensive geriatric assessment in a hospital at
home setting)
Methods Parallel RCT; economic evaluation; qualitative interviews
Participants Older people with markers of frailty or prior dependence who have been referred to admission avoidance
hospital at home for an acute medical event
Interventions Intervention: specialist-led service providing assessment and a tailored management plan, multidisciplinary
management, and co-ordinated care in the patient’s own home
Comparison: care as usual
Outcomes Main outcome: living at home (the inverse of death or living in a residential care setting) Follow-up at 6 and
12 months
Other outcomes: activities of daily living; cognitive impairment; delirium;mortality; new long-term residential
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ISRCTN60477865 (Continued)
care; quality of life; resource use; transfer to hospital
Starting date 30 November 2014
Contact information
Notes ISRCTN60477865
DECAF: Dyspnea, Eosinopenia, Consolidation, respiratory Acidosis and atrial Fibrillation
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Admission avoidance hospital at home versus inpatient care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality at 3 months using IPD 5 mortality (Fixed, 95% CI) 0.77 [0.54, 1.09]
2 Mortality at 6 months’ follow-up
(using data from trialists, apart
from Caplan)
6 912 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.60, 0.99]
3 Readmission or transfer to
hospital while receiving
hospital at home
Other data No numeric data
4 Readmission to hospital for
patients with a medical
condition at an average of 5
months’ follow-up
7 834 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.77, 1.23]
4.1 Readmission for older
patients with a medical
condition using IPD and
published data
7 834 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.77, 1.23]
5 Functional status Other data No numeric data
5.2 Admission avoidance
patients with a medical
condition - functional ability
Other data No numeric data
6 Quality of life/health status Other data No numeric data
6.1 Admission avoidance
quality of life
Other data No numeric data
7 Cognitive function and
depression
Other data No numeric data
7.1 admission avoidance -
cognitive function/well being
Other data No numeric data
8 Clinical outcomes Other data No numeric data
8.1 Clinical outcomes Other data No numeric data
9 Place of residence at follow-up
(living in residential care)
5 727 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.22, 0.57]
9.1 With a medical condition
(6 months follow up)
5 727 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.22, 0.57]
10 Patient satisfaction Other data No numeric data
11 Care giver outcomes Other data No numeric data
11.1 Care giver satisfaction Other data No numeric data
12 Views of health professionals Other data No numeric data
13 Length of stay Other data No numeric data
13.1 Hospital and hospital at
home length of stay
Other data No numeric data
14 Resources and costs Other data No numeric data
14.1 Health service resources
and costs
Other data No numeric data
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14.2 Use of other social
services
Other data No numeric data
14.3 Informal care inputs Other data No numeric data
Analysis 1.1. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 1
Mortality at 3 months using IPD.
Review: Admission avoidance hospital at home
Comparison: 1 Admission avoidance hospital at home versus inpatient care
Outcome: 1 Mortality at 3 months using IPD
Study or subgroup log [mortality] mortality Weight mortality
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Davies 2000 -0.066 (0.627) 8.2 % 0.94 [ 0.27, 3.20 ]
Harris 2005 2.0202 (1.4285) 1.6 % 7.54 [ 0.46, 123.97 ]
Kalra 2000 -0.372 (0.393) 20.8 % 0.69 [ 0.32, 1.49 ]
Ricauda 2004 -0.465 (0.348) 26.5 % 0.63 [ 0.32, 1.24 ]
Wilson 1999 -0.201 (0.273) 43.0 % 0.82 [ 0.48, 1.40 ]
Total (95% CI) 100.0 % 0.77 [ 0.54, 1.09 ]
Heterogeneity: Chi2 = 3.12, df = 4 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours hospital at home Favours inpatient care
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Analysis 1.2. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 2
Mortality at 6 months’ follow-up (using data from trialists, apart from Caplan).
Review: Admission avoidance hospital at home
Comparison: 1 Admission avoidance hospital at home versus inpatient care
Outcome: 2 Mortality at 6 months’ follow-up (using data from trialists, apart from Caplan)
Study or subgroup Admission avoidance Inpatient care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Caplan 1999 6/51 7/49 6.5 % 0.82 [ 0.30, 2.28 ]
Kalra 2000 15/141 24/149 21.2 % 0.66 [ 0.36, 1.21 ]
Ricauda 2004 18/60 24/60 21.8 % 0.75 [ 0.46, 1.23 ]
Ricauda 2008 9/52 12/52 10.9 % 0.75 [ 0.35, 1.63 ]
Tibaldi 2009 7/48 8/53 6.9 % 0.97 [ 0.38, 2.46 ]
Wilson 1999 30/101 35/96 32.6 % 0.81 [ 0.55, 1.22 ]
Total (95% CI) 453 459 100.0 % 0.77 [ 0.60, 0.99 ]
Total events: 85 (Admission avoidance), 110 (Inpatient care)
Heterogeneity: Chi2 = 0.58, df = 5 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.07 (P = 0.038)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.3. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 3
Readmission or transfer to hospital while receiving hospital at home.
Readmission or transfer to hospital while receiving hospital at home
Study Outcomes Results
Corwin 2005 Transfer to hospital T= 11/98, C=3/96
Kalra 2000 Readmission within 2 weeks of randomisation T= 51/149
Ricauda 2008 Transferred to acute hospital T= 3/52
Richards 2005 T= 2/24, C= 1/25
Talcott 2011 Readmission to hospital while receiving hospital at home T= 4/47, C= 0/66
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Analysis 1.4. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 4
Readmission to hospital for patients with a medical condition at an average of 5 months’ follow-up.
Review: Admission avoidance hospital at home
Comparison: 1 Admission avoidance hospital at home versus inpatient care
Outcome: 4 Readmission to hospital for patients with a medical condition at an average of 5 months’ follow-up
Study or subgroup Admission avoidance Inpatient care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Readmission for older patients with a medical condition using IPD and published data
Caplan 1999 (1) 7/51 5/49 5.1 % 1.35 [ 0.46, 3.96 ]
Davies 2000 (2) 37/100 17/50 22.6 % 1.09 [ 0.68, 1.73 ]
Harris 2005 (3) 2/39 1/37 1.0 % 1.90 [ 0.18, 20.05 ]
Mendoza 2009 (4) 15/37 17/34 17.7 % 0.81 [ 0.48, 1.36 ]
Ricauda 2008 (5) 17/52 34/87 25.4 % 0.84 [ 0.52, 1.34 ]
Tibaldi 2009 (6) 8/48 18/53 17.1 % 0.49 [ 0.24, 1.02 ]
Wilson 1999 (7) 21/101 11/96 11.2 % 1.81 [ 0.92, 3.56 ]
Total (95% CI) 428 406 100.0 % 0.98 [ 0.77, 1.23 ]
Total events: 107 (Admission avoidance), 103 (Inpatient care)
Heterogeneity: Chi2 = 8.38, df = 6 (P = 0.21); I2 =28%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
(1) Caplan published data
(2) Davies published data: admission avoidance hospital at home: 37/100; inpatient admission: 17/50
(3) Harris unpublished data
(4) Mendozza published data, 12 months follow-up
(5) Ricauda published data; 6 months follow-up
(6) Tibaldi published data; 6 months follow-up
(7) Wilson published data: admission avoidance hospital at home: 21/101; inpatient admission: 16/96
Analysis 1.5. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 5
Functional status.
Functional status
Study Functional ability Results
Admission avoidance patients with a medical condition - functional ability
Caplan 1999 Change in Barthel score from admission to discharge
(high score=greater independence)
Instrumental activities of daily living score from admis-
Mean (SEM)
T= 0.37 (0.27), C= -0.04 (0.27), NS
Mean (SEM)
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Functional status (Continued)
sion to discharge (higher score=greater independence) T= 0.65 (0.23), C= -0.88 (0.26), P = 0.037
Davies 2000 St Georges’ respiratory questionnaire (to a random sub-
group of 90 participants)
High score indicates poorer health related quality of life.
A minimum change in score of 4 units is clinically rele-
vant.
Forced expiratory volume in one second (FEV1)
Baseline scores
T= 71.5 (43.4 to 99.6), C= 71.0 (43.4 to 98.6)
Mean (SD) change at 3 months
T= 0.48 (16.92) C= 3.13 (14.02)
Forced expiratory volume in 1 second (FEV1)
At 3 months:
T= 41.5% (95% CI 8.2% to 74.8%)
C= 41.9% (95% CI 6.2% to 77.6%)
Kalra 2000 Modified Rankin scale 0-3 (measure of dependence: 0=
independent and 3=dependent)
Number independent and require minor assistance for
day to day activities.
Barthel 0-20 (higher score=greater independence)
Modified Rankin
At 3 months
T= 107/145 (74%)
C= 111/151 (74%)
RR 1.00 (0.86, 1.15), P = 0.96
At 12 months
T= 102/144 (71%)
C= 99/149 (66%)
RR 0.94 (0.81, 1.09), P = 0.42
Barthel 15-20 (number with favourable outcome)
At 3 months
T= 106/145 (73%)
C= 106/151 (70%)
RR 0.96 (0.83, 1.11), P = 0.58
At 12 months
T= 102/144 (71%)
C= 102/149 (69%)
RR 0.97 (0.85, 1.11), P = 0.65
Mendoza 2009 Activities of daily living Mean score Barthel Index at 1 year (adjusted for base-
line differences)
T= 4.0 (-0.9 to 8.9)
C= 4.7 (-2.2 to 11.5)
P = 0.21
Ricauda 2004 Activities of daily living (number of functions lost, score
0 to 6).
Functional impairment measure (level of independence,
range 28 to 126
High score =greater independence
Canadian Neurological Scale Score (higher score=im-
provement, range 0-10)
Activities of daily living
At 6 months (Median (IQR))
T= 4 (2-5), C= 4 (2-6), P = 0.57 (Mann Whitney)
Functional impairment measure
At 6 months (Median (IQR))
T= 106 (67.5-121.5), C= 96.5 (56.5-116.5), P = 0.26
(Mann Whitney)
Canadian Neurological Scale Score
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Functional status (Continued)
National Institute ofHealth Stroke Scale Score (low score
=improvement; range 0-36)
At 6 months (Median (IQR))
T= 10 (8.5-10.0), C= 9.5 (7.0-10.0), P = 0.39 (Mann
Whitney
National Institute of Health Stroke Scale Score
At 6 months (Median (IQR))
T= 8 (4-26), C= 8 (6-24), P = 0.37 (Mann Whitney)
Ricauda 2008 Change in ADL (score 0 to 6) At 6 months, mean (SD)
T= 0.12 (0.64), C= 0.08 (0.73), P = 0.81
Tibaldi 2004 Behavioural disturbances Sleeping disorders
T= 5/56 (9%), C= 23/53 (43%), MD: -34%, 95% CI -
50% to -19%, P < 0.001
Agitation/aggressiveness
T= 5 /56 (9%), C= 22/53 (41.5%), MD -33% 95% CI
-48% to -17%, P<0.001
Feeding disorders
T= 5 /56 (9%), C= 21/53 (40%), MD -31% 95% CI -
46% to -16%, P < 0.001
Tibaldi 2009 Activities of daily living
Barthel Index
ADL at 6 months mean change
T= -1.95 (9.61) N=48, C= -0.30 (10.12) N=53,
Wilson 1999 Barthel Index Barthel Index
At 3 months (Median (IQR))
T= 16 (13-19), C= 16 (12-20)
Barthel Index - number (%) not assessed:
T= 21 (28%), C= 18 (28%)
Sickness Impact Profile:
At 3 months (Median (IQR))
T= 24 (20-31), C= 26 (20-31)
Sickness Impact Profile - no (%) not assessed
T= 31 (41%), C= 30 (46%)
Analysis 1.6. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 6
Quality of life/health status.
Quality of life/health status
Study Outcomes Results Notes
Admission avoidance quality of life
Corwin 2005 SF 36
Physical functioning
Role physical
SF 36
Physical functioning
Differences calculated on absolute
differences between day 0 & day 3,
51Admission avoidance hospital at home (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Quality of life/health status (Continued)
Pain Day 3
T= 37 (29.1), C= 41 (28.3)
Mean difference -1.9, 95% CI -10.7
to 6.9
Day 6
T=50.7 (33.7), C=50.9 (31.6)
Mean difference -5.2, 95% CI -13.7
to 3.2
Role physical
Day 3
T= 5.4 (18.8), C=5.5 (19.7)
Mean difference -1.8 95% CI -13.1
to 9.4
Day 6
T=21.1 (36.9), C=18.4 (36.5)
Mean difference 2.2, 95% CI -10.7
to 15.1
Pain
Day 3
T=57 (28.8), C=55.9 (25.4)
Mean difference -2.5 95% CI -10.1
to 5.1
Day 6
T=69.8 (26.4), C=64.8 (25.6)
Mean difference -3.8 95% CI -10.6
to 3.0
or day 0 & day 6.
Numbers vary due to missing data
(high score=better health)
Mendoza 2009 SF 36
Physical component
Mental component
Physical component
T= 3.6 (-0.5 to 7.7), C= 2.2 (-1.9 to
6.4), P = 0.47
Mental component
T= 4.0 (-0.9 to 8.9), C= 2.8 (-2.4 to
8.0), P = 0.38
Score at 1 year (adjusted for baseline
differences)
Ricauda 2008 Nottingham Health Profile 6 months, mean (SD)
T= 3.6 (7.9), C= 0.8 (4.5), P = 0.04
Changes at 6 months
Richards 2005 SF-12 Mean physical and mental
component score
Physical component
At 2 weeks
T= 38.1, C= 40.2, P = 0.45
At 6 weeks
T= 42.2, C=45.8, P = 0.18
Mental component
At 2 weeks
T=48.3, C=48.6, P = 0.91
At 6 weeks
higher score=better health
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Quality of life/health status (Continued)
T = 50.4, C=51.0, P = 0.81
Talcott 2011 Quality of life EORTC QLQ C-30 Role Function
T= 0.58, C= 0.78, P = 0.05
Emotional Function
T= 3.27, C= -6.94, P = 0.04
Quality of life data were collected at
the time of consent to join the study,
as soon as possible after the resolution
of the episode.
Data were collected for the first study
episode.
Change score
Tibaldi 2009 Nottingham Health Profile 6 months, mean (SD)
T= +1.09 (2.57), C= +0.18 (1.94), P
= 0.046
Wilson 1999 Sickness Impact Profile (SIP)
Euroqol
SIP, median (IQR)
T= 24 (20-31), C= 26 (20-31)
Difference -2 (95% CI -4 to 4), P =
0.73
Euroqol, median
T= 0.64, C= 0.63
Difference 0.01 (95% CI -0.12 to 0.
09), P = 0.94
At 3 months follow-up
Analysis 1.7. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 7
Cognitive function and depression.
Cognitive function and depression
Study Outcomes Results
admission avoidance - cognitive function/well being
Caplan 1999 Mental status questionnaire score from admission to dis-
charge (maximum score 10);
Number with confusion
Mean (SEM)
T= 0.43 (0.12), C= 0.27 (0.12), NS
Number with confusion
T=0/51, C=10/49
Ricauda 2004 Geriatric Depression Scale score (range 0-30)
higher scores indicate depression
Change in Mini Mental State Exam (score 0 to 30)
At 6 months, median (IQR)
T= 10 (5-15), C=17 (13-20), P<0.001 (Mann Whitney)
At 6 months, mean (SD)
T= -0.4 (4.0), C=-0.5 (1.8), P = 0.88
Ricauda 2008 Change in geriatric Depression Scale score (range 0-30)
higher scores indicate depression
At 6 months, mean (SD)
T= -3.1 (4.7), C=0.7 (3.2), P < 0.0001
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Cognitive function and depression (Continued)
Tibaldi 2009 Mini Mental State Exam (MMSE)
Geriatric Depression Scale
At 6 months, mean change (SD)
T= +0.07 (1.38), C= +0.08 (1.36), P = 0.97
At 6 months, mean change (SD)
T= +1.48 (1.86), C= +0.12 (3.36), P = 0.02
Wilson 1999 Philadelphia Geriatric Morale Scale At 3 months, median (IQR)
T= 37 (30-42), C= 37 (31-43), Difference 0, 95% CI -
4.1 to 4.1
Analysis 1.8. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 8
Clinical outcomes.
Clinical outcomes
Study Outcomes Results
Clinical outcomes
Corwin 2005 No advancement of cellulitis
(indelible line drawn around peripheral margin of the
cellulitis and dated)
Mean (SD) days
T= 1.5 (0.11), C= 1.49 (0.10),Mean difference 0.01 days,
95% CI -0.3 to 0.28
Days of no advancement of cellulites
HR 0.98, 95% CI 0.73 to 1.32, P = 0.90
Days on intravenous antibiotics
HR 0.84, 95% CI 0.63 to 1.12, P = 0.23
Days to discharge
HR 0.93, 95% CI 0.70 to 1.23, P = 0.60
Days on oral antibiotics
HR 1.09, 95% CI 0.82 to 1.45, P = 0.56
Davies 2000 Proportion of patients prescribed an antibiotic at 3
months
T= 56/100 (56%), C= 19/50 (38%), Difference 18%,
95% CI 1.4 to 34.6%
Talcott 2011 Major medical complications during care in hospital at
home or hospital
T= 4/47 (9%), C= 5/66 (8%), Difference 1%, 95% CI -
10 to13%
Tibaldi 2004 Use of antipsychotic drugs On admission
T= 26/56 (46.4%), C= 18/56 (32%), Difference 14.3%,
95% CI -3.7% to 31.1%
On discharge
T= 6/56 (11%), C = 13/53 (25%), Difference 14%, 95%
CI -28% to 0.3%
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Analysis 1.9. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 9 Place
of residence at follow-up (living in residential care).
Review: Admission avoidance hospital at home
Comparison: 1 Admission avoidance hospital at home versus inpatient care
Outcome: 9 Place of residence at follow-up (living in residential care)
Study or subgroup Admission avoidance Inpatient care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 With a medical condition (6 months follow up)
Kalra 2000 15/144 12/149 19.7 % 1.29 [ 0.63, 2.67 ]
Ricauda 2004 (1) 3/60 16/60 26.7 % 0.19 [ 0.06, 0.61 ]
Ricauda 2008 0/52 6/52 10.9 % 0.08 [ 0.00, 1.33 ]
Tibaldi 2004 (2) 2/56 17/53 29.2 % 0.11 [ 0.03, 0.46 ]
Tibaldi 2009 0/48 8/53 13.5 % 0.06 [ 0.00, 1.09 ]
Total (95% CI) 360 367 100.0 % 0.35 [ 0.22, 0.57 ]
Total events: 20 (Admission avoidance), 59 (Inpatient care)
Heterogeneity: Chi2 = 18.46, df = 4 (P = 0.001); I2 =78%
Test for overall effect: Z = 4.26 (P = 0.000021)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
(1) At discharge: Ricauda 2008; Tibaldi 2004; Tibaldi 2009. 6 month follow-up: Kalra 2000; Ricauda 2004.
(2) Tibaldi 2004 recruited people with dementia
Analysis 1.10. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 10
Patient satisfaction.
Patient satisfaction
Study Outcomes Results Notes
Caplan 1999 Satisfaction rated on a 4 point scale:
1=excellent, 2=good, 3=fair, 4=poor
Mean score
T= 1.1, C= 2.0, P < 0.0001
Response rates were 78% for the
treatment group, and 40% for the
control
Corwin 2005 Patient satisfaction questionnaire
(not described)
Overall
T= 87/91 (96%), C=87/96 (96%), P
= 0.12
Satisfaction with location of care
T= 85/91 (93%), C= 59/88 (66%),
P < 0.0001
Location preference
Numbers for control group vary be-
tween 88 and 91 due to missing data
Proportion of participants satisfied or
very satisfied
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Patient satisfaction (Continued)
In the hospital
T= 5/91 (5%), C= 27/88 (31%)
In the community
T= 78/91 (86%), C= 31/88 (35%)
No preference
T= 8/91 (9%), C= 30/88 (34%)
P < 0.0001
Ricauda 2008 Patient satisfaction questionnaire
(not described)
T= 49/52 (94%), C= 46/52 (88%),
P = 0.83
Proportion of participants rating sat-
isfaction as very good/excellent at dis-
charge
Richards 2005 Outcome not described T= 24/24 (100%), C= 14/24 (60%)
, P = 0.001
Proportion of patients very happy
with care
Wilson 1999 Patient satisfaction, scale 0 to 18 Median (IQR)
T= 15 (13 to 16.5), C= 12 (11 to 14)
, P < 0.0001
At 2 weeks, or discharge
Analysis 1.11. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 11
Care giver outcomes.
Care giver outcomes
Study Outcomes Results Notes
Care giver satisfaction
Caplan 1999 Carer satisfaction Mean score
T= 1.1, C= 1.9, P < 0.0001
Satisfaction rated on a 4 point scale:
1=excellent, 2=good, 3=fair, 4=poor
Ricauda 2008 Change in
Relative’s Stress Scale Score
At 6 months, mean (SD)
T= 4.6 (5.6), C= 2.6 (6.1), P = 0.16
Analysis 1.12. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 12
Views of health professionals.
Views of health professionals
Study Outcomes Results Notes
Caplan 1999 GP satisfaction Mean score (95% CI)
T= 1.7 (1.4 to 2.0), C= 1.8 (1.4 to 2.2), Differ-
ence: NS
Higher scores indicate higher satisfaction
Response rate:
T: 63%, C: 37%
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Analysis 1.13. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 13
Length of stay.
Length of stay
Study Results Outcomes Notes
Hospital and hospital at home length of stay
Davies 2000 Hospital length of stay Median (IQR)
5 days (4 to 7)
N=100
Mean (SD)
6.72 days (4.3)
N=100
Data for the control group only
Harris 2005 Average length of stay for the index
episode
until discharge from hospital
or hospital at home (days)
T= 11.33 days (SD 11.14) N=39, C=
7.83 days (7.35) N=37 Mean differ-
ence 3.5 95% CI -0.80 to 7.80
IPD
Kalra 2000 Average length of stay for readmis-
sion
within two weeks of discharge (T) or
index episode (C) (days)
T= 48.6 (SD 26.7) N=51/146, C=
29.5 (SD 40.1) N=151
Difference 16.6, 95% CI 7.9 to 25.3
Data for inpatients treated by a stroke
team
Mendoza 2009 Average length of stay for the index
episode (days)
T= 10.9 (SD 5.9) N=37, C= 7.9 (SD
3.0), P = 0.01 N=34
Ricauda 2004 Average length of treatment (days) T= 38.1 (SD 28.6) N=60, C= 22.2
(11.5) N=60
Difference 15.90, 95% CI 8.10 to
23.70
Ricauda 2008 Hospital at home and hospital length
of stay (days)
Total length of stay to include hospi-
tal transfers for the hospital at home
group
Total days of care (hospital plus hos-
pital at home), mean (SD)
T= 15.5 (SD 9.5) N=52, C= 52 (SD
7.9)
Difference 4.50, 95% CI 1.14, 7.86
Richards 2005 Median number of days to discharge T=4 (range 1-14) N=24, C= 2 (range
0-10) N=25
Tibaldi 2009 Time in the emergency department
(hours)
Length of stay (days)
Time in ED, mean (SD)
T= 14.6 (3.4), C= 16.3 (3.0)
Length of treatment, mean (SD)
T= 20.7 (6.9) N=48, C= 11.6 (10.7)
N=53, P = 0.001
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Length of stay (Continued)
Wilson 1999 Length of stay Treatment N=102 Control N=97
Length of hospital stay in days, me-
dian
T= 5.1 (13.53), C= 18.5 (18.51)
days, P = 0.026
Total days of care (hospital plus hos-
pital at home), median
T= 9, C= 16 days; P = 0.031
Total days of care (hospital plus hos-
pital at home and readmission days)
, mean (SD)
T= 13.33 (17.26), C= 21.42 (25.46)
Difference -8.09 95% CI -14.34 to -
1.85
Analysis 1.14. Comparison 1 Admission avoidance hospital at home versus inpatient care, Outcome 14
Resources and costs.
Resources and costs
Study Outcomes Results Notes
Health service resources and costs
Caplan 1999 Cost Average cost per episode, mean (SD)
T=$1,764 ($1,253),C= $3,775 ($2,
496)
Mean difference per episode $-2011
Cost per day, mean (SD)
T= $191 ($58), C= $484 ($67.23)
Mean difference per day -$293
Cost data financial year 1995/1996
Corwin 2005 Days on oral antibiotics HR 1.09 (0.82 to 1.45), P = 0.56
Mendoza 2009 Cost Mean (SD)
T= EURO2,541 (1,334), C=
EURO4,502 (2,153)
Difference EURO1,961 P < 0.0001
Difference attributed to fewer inves-
tigations. Costs include health ser-
vice costs used during follow-up pe-
riod of 1 year, excludes informal care
Nicholson 2001 Costs Cost per episode, mean (95% C)
T= $745 ($595 to $895),C= $2543
($1766 to $3321)
Difference $1798, P < 0.01
Hospital at home costs
Costs based on financial year 99/00;
Used average DRG costs (Australian
$), patient data for ED costs, and
modelled costs for OPD clinic visits.
HAH care individual costs, included
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Resources and costs (Continued)
29% of the average hospital man-
aged patient episode. Reported cost
effectiveness ratio of 3:1
T + C costs
GP 10% of costs, Domiciliary al-
lied health 21%of costs, community
nursing 28% of costs = 59% of costs
and hospital care 41% of costs.
If C=$895 then T= $1287 (59% of
costs)
Total costs=$2182 per patient
episode of care
direct and non direct costs. GP costs
at $91.00 per hour
Ricauda 2004 Mean total cost (EUR converted to
US$ 1 Euro=$1.3)
T= $6 413.5 per patient, C= $6 504.
8 per patient
Cost per patient per day (SD)
T= $163 (20.5), C= $275.6 (27.7)
P < 0.001
Ricauda 2008 Hospital at home resources
Total costs
Nursing visits (range)
T= 14.1 (3 to 38)
Physician visits
T= 9.9 (2 to 28)
Visits to hospital for diagnosis
T= 11
Total mean cost per patient
T=$1,175.9, C= $1,390.9, P = 0.38
Total mean cost per day (SD)
T= $101.4 (61.3), C= 151.7 (96.4)
Richards 2005 Cost based on DRGs for control and
actual cost for intervention
Mean cost per patient NZ$
T= $1157.9, C= $1556.28
Wilson 1999 Cost Cost of initial episode (95% CI)
T= £2,568.9 (2,089.3 to 2,972.1)
C= £2,880.6 (2,316.1 to 3,547.8)
Difference -311.7, P > 0.43
Bootstrap difference using 1000 sub-
samples: -304.72 (-1,112.4 to 447.
9).
Mean cost per day (95% CI)
T= £204.6 (91.5 to 118.4)
C= £104.9 £ (181.1 to 228.22)
Mean difference £99.71 P < 0.001
Cost data financial year 1995/1996
BNF for medicines 1995
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Resources and costs (Continued)
Cost at 3 months (95% CI)
T= £3,671.3 (3,140.5 to 4,231.3)
C= £3,876.9 (3,224.51 to 4,559.6)
Difference -205.7, P > 0.65
Bootstrap difference using 1000 sub-
samples: -210.9 (-1,025 to 635.5)
COSTS EXCLUDING
REFUSERS
Cost of initial episode, mean (95%
CI)
T= £2,594.4 (£2,170.36 to £3,143.
5)
C= £3,659.20 (£3,140.46 to £4,
231.28)
Mean difference -£1,064.79, P < 0.
01.
Bootstrap mean difference £1070.
53, (95% CI-£1843.2 to -£245.73)
95% CI derived using bootstrap
method with 1000 subsamples
Cost per day, mean (95% CI)
T= £206.68 (£183.21 to £230.14)
C= £133.7 (£124.6 to £142.8)
Mean difference £72.98, P < 0.001
Cost at 3 months, mean (95% CI)
T= £3,697.5 (£3136.13 to £4330.
66)
C= £4,761.3 (£4105.6 to £5476.6)
Mean difference -£1,063.8, p = 0.
025
Bootstrap mean difference: £1,063.
45 (95% CI -£2043.8 to -£162.7)
Use of other social services
Davies 2000 While receiving hospital at home
care, or on discharge from hospital
Referred for increased social support
T= 24/100 (24%), C= 3/50 (6%)
Difference 18%, 95% CI 7.3% to
28.6%
Informal care inputs
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Resources and costs (Continued)
Kalra 2000 Informal care inputs Received informal care:
T= 100/140 (71%), C= 98/147
(67%), Difference 4.8%, 95% CI -
5.9% to 15.3%
Total from co residents over 12
months, hours (SD)
T= 899.18 (1760), C= 718 (6778),
P = 0.75
Total hours per average week from
co residents (SD)
T=46.38 (48.15), C= 33.71 (44.35)
, P = 0.02
Total hours from nonresidents over
12 months (SD)
T= 79.7 (283), C= 127.44 (348), P
= 0.27
Total average hours per week from
non residents
T= 4.79 (16.51), C= 5.03 (11.54),
P = 0.88
Total hours over 12 months (SD)
T= 979 (1749), C= 846 (1549), P =
0.49
A P P E N D I C E S
Appendix 1. Search strategies
Ovid MEDLINE(R) and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations (1946 to 2 March 2016)
1 (hospital adj2 home).tw.
2 home based versus hospital based.tw.
3 home hospitalization.tw.
4 exp Home Care Services/
5 exp Hospitalization/
6 4 and 5
7 1 or 2 or 3 or 6
8 randomized controlled trial.pt.
9 controlled clinical trial.pt.
10 randomized.ab.
11 placebo.ab.
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12 drug therapy.fs.
13 randomly.ab.
14 trial.ab.
15 groups.ab.
16 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
17exp animals/ not humans.sh.
18 16 not 17
19 7 and 18
EMBASE (1974 to 1 March 2016)
1 (hospital adj2 home).tw.
2 home hospitalization.tw.
3 home based versus hospital based.tw.
4 exp home care/
5 hospitalization/
6 4 and 5
7 1 or 2 or 3 or 6
8 clinical trial/
9 randomization/
10 randomized controlled trial/
11 crossover procedure/
12 double blind procedure/
13 single blind procedure/
14 (randomised or randomized).tw.
15 placebo/
16 (controlled adj study).tw.
17 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18 7 and 17
19 nonhuman/
20 18 not 19
CINAHL - Cumulative Index to Nursing & Allied Health Literature (1982 to 2 March 2016)
1 TI hospital N2 home OR AB hospital N2 home
2 TI Home-based versus hospital-based OR AB Home-based versus hospital-based
3 TI Home hospitalization OR AB Home hospitalization
4 (MH “Home Health Care”)
5 (MH “Hospitalization”)
6 4 AND 5
7 1 OR 2 OR 3 OR 6
8 (MH “Clinical Trials+”)
9 PT clinical trial
10 TI ( controlled trial or controlled study ) OR AB ( controlled trial or controlled study )
11 TI ( randomised or randomized ) OR AB ( randomised or randomized )
12 TI ( (random* N1 (allocat* or assign*)) ) OR AB ( (random* N1 (allocat* or assign*)) )
13 8 OR 9 OR 10 OR 11 OR 12
14 6 AND 13
Cochrane Central Register of Controlled Trials (Issue 2 of 12, 2016)
#1 hospital near/2 home:ti,ab,kw (Word variations have been searched)
#2 home hospitalization:ti,ab,kw (Word variations have been searched)
#3 Home-based versus hospital-based :ti,ab,kw (Word variations have been searched)
#4 #1 or #2 or #3
EconLit (1969 to 2 March 2016)
S5 (hospital NEAR/2 home) OR “home hospitalization” OR “home based versus hospital based”Limits applied
S4 (hospital NEAR/2 home) OR “home hospitalization” OR “home based versus hospital based”
S3 “home based versus hospital based”
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S2 “home hospitalization”
S1 hospital NEAR/2 home
Appendix 2. Search strategy for EPOC register
21 February 2007
home-based near in-patient*
homecare near in-patient*
hospital-at-home near in-patient*
home-based near hospital*
homecare or home-care near hospital*
home hospital* and in-patient*
21 January 2008 revision
home-based and in-patient*
homecare and in-patient*
hospital-at-home and in-patient*
home-based and hospital*
homecare and hospital*
home-care and hospital*
home hospital* and in-patient*
WH A T ’ S N E W
Date Event Description
2 March 2016 New search has been performed New searches performed. Six new trials identified.
2 March 2016 New citation required but conclusions have not changed Daniela C Gonçalves-Bradley is a new author; the review
includes 16 trials (6 trials included in this update). Meth-
ods have been updated to align with current Cochrane
guidance
H I S T O R Y
Date Event Description
6 July 2011 Amended Reference revised to published review.
8 June 2011 Amended Title changed for consistency and changes to published notes
17 February 2010 Amended Change to published notes.
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(Continued)
1 August 2008 New search has been performed This review is an updated search and partial update from the original review
(Shepperd 1998). Shepperd 1998 has been split into three reviews, of which
this is one.
10 July 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
SS co-ordinated the review, screened records, extracted data, analysed the results (with HD), and lead the writing of the review.
SI screened records, extracted data, and commented on each draft of the review.
DGB screened records, extracted data, and contributed to the writing of the review.
HD, MJC, LK, and ADW all contributed to interpretation of data and writing the review.
Two of the review authors (LK, AW) contributed trial data to the individual patient data meta-analysis.
D E C L A R A T I O N S O F I N T E R E S T
SS None known.
SI None known.
HD None known.
MC None known.
LK None known.
AW None known.
DGB None known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
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External sources
• NIHR Research Scientist in Evidence Synthesis Award to Sasha Shepperd supported this work, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made a posteriori decisions on how to analyse missing data. We updated the methods to align with current Cochrane guidance
(MECIR 2012). The authorship has changed since the publication of the protocol, with the addition of Helen Doll, Mike J Clarke,
Lalit Kalra, Nicoletta Aimonino Ricauda, Andrew D Wilson, and Daniela C Gonçalves-Bradley.
N O T E S
This review is the third update; the original review was first published in Issue 1, 1998 of the Cochrane Library (Shepperd 1998).The
original review has been separated into three distinct reviews: Hospital at home admission avoidance, Hospital at home early discharge,
and Hospital at home: home-based end-of-life care. The titles have been changed for consistency. Hospital at home early discharge,
Shepperd 2009, and Hospital at home: home-based end-of-life care, Shepperd 2011, are published in the Cochrane Library.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Home Care Services [economics; ∗organization & administration]; Home Care Services, Hospital-Based [economics; ∗organization &
administration]; Hospitalization; Outcome and Process Assessment (Health Care); Randomized Controlled Trials as Topic
MeSH check words
Humans
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